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Summary  
 
At the post genomics age, the study of proteomics attracts more and more attention and help 
to decipher the hidden information inside genes. However, the study of proteomics required large 
amount or large number of proteins to be synthesized. During the past several decades, heterologous 
overexpression of recombinant protein from bacteria, yeast, insect cells and mammalian cells was 
developed. Especially the E. coli system, which is the most studied expression system, was used to 
obtain different recombinant proteins from both prokaryotic and eukaryotic organisms. Still, there 
are a large number of eukaryotic proteins that cannot be functionally overexpressed in the E. coli 
system. Techniques were developed to overexpress recombinant protein in eukaryotic host cells 
including yeast, insect cells and mammalian cells. However, these eukaryotic overexpression 
systems normally require more complicated processes and take more time to finally get the protein. 
Cell-free (CF) expression systems, using cell lysates, which contain the required enzymes, extra 
energy resources and substrates needed for translation, were developed. The CF system was first 
used to discover the genetic code by in vitro translation of poly-U RNA sequences. Later on, it was 
applied to protein synthesis, attracted more attention and became an alternative method for protein 
expression besides traditional cell based expression systems.  
Eliminating the need of viable cells opens the CF expression system for various 
modifications. The CF expression system was widely used to express difficult target proteins like 
toxins, membrane proteins (MPs), insoluble or aggregation-prone proteins that failed to be 
expressed in in vivo. The open nature and emendation for throughput automation made the CF 
system an ideal system for proteome research. In this thesis, a high throughput CF expression 
platform, in particular, addressing difficult targets including MPs and aggregation prone proteins is 
developed. 
In order to establish the high-throughput CF expression platform, a batch configuration 
which is less time consuming, was selected. The amount of protein expressed in low-volume batch 
configurations can be addressed by more sensitive detection methods. With the TECAN Freedom 
EVO 200 liquid handling robot, the full automation of the CF expression system was achieved. This 
platform provides parallel expressions in 96-well plates with a minimum volume of 25 µl. The 
whole expression takes 2-4 hours with an expression yield above 0.5 mg per 1 ml reaction mixture. 
A custom designed software E.Y.E.S which provides a more versatile and friendly user interface to 
design the screening of CF expression conditions, was created. With the help of E.Y.E.S program 
the time for robot programming and pipetting was largely reduced. The whole pipetting time was 
reduced to 30-45 minutes for 96 reactions. The high-throughput expression optimization can be 
combined with fluorescence detection by fusing shifted green fluorescent protein (sGFP) to the 
target protein, allowing a fast read out. 
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With the established high-throughput CF expression system, we systematically screened the 
effect of common chemical stabilizers. The sGFP was chosen as a target protein. In the first step, the 
compatibility of the selected chemical stabilizers was evaluated by measuring the fluorescence of 
CF expressed sGFP. With these experiments, the effect of selected stabilizers can be classified into 
three different types: positive, negative and tolerant. In case of a positive effect, the selected 
stabilizer increased the expression or folding of sGFP, which resulted in an increase of the measured 
fluorescence. A negative effect indicated that selected chemical compounds were toxic to the CF 
expression system and inhibited the expression at low compound concentrations. A tolerant effect 
represented that the expression of sGFP in CF system had a linear decrease with the increase 
concentration of this type of chemical stabilizers. Those stabilizers which had a positive or tolerant 
effect on the CF expression system can be used and applied to those unstable protein or aggregation 
prone proteins to improve the solubility and stability of the sample as soon as they were expressed. 
In order to check the application of these chemical stabilizers, we choose two targets. One is human 
GNA1 (EC 2.3.1.4)  which catalyzes the transfer of  the Acetyl group from Acetyl Coenzyme A 
(AcCoA) to the primary amine of D-glucosamine-6-phosphate to form N-acetyl-D-glucosamine-6-
phosphate (GlcNAc-6P) and Coenzyme A (CoA). Another target is CurA-halogenase, which is the 
first enzyme within the biosynthesis of curacin A (a bioactive compound with potent anti-
proliferative activity) pathway. The biosynthesis of CurA is mediated by a 2.2 MDa hybrid 
polyketide synthase (PKSs) and non-ribosomal peptide synthetases (NRPSs). Both of the two 
targets were expressed as partially soluble in vivo and in vitro. We selected several chemical 
stabilizers to check the ability of these chemical stabilizers to improve the soluble expression of the 
selected two targets in CF expression system. For the case of halogenase, a maximum of around 25% 
increased soluble expression was observed with choline. For GNA1, a beneficial effect of choline 
was also observed. To further check if the fluorescence signals from the protein fused with sGFP 
correlated with the function of the fusion partners, we created a GNA1-sGFP construct which sGFP 
was fused at the C-terminal of GNA1. Results of the experiment showed that the function of GNA1 
was not always correlated with the fluorescence signal from sGFP. In the case of L-arginine, the 
fluorescence of the fusion protein was increased without the increase of the functionality of GNA1, 
which might explained by that L-arginine had a beneficial effect on the sGFP folding. While for the 
case of choline, the increase of fluorescence signal correlated with the functional assay. Finally, in 
order to provide an example of correlated screening of two chemical compounds, we select 
PEG8000 and choline to perform this experiment. When using PEG8000 alone, an increase of 
soluble expression was observed around 17% was observed. While with choline alone around 23% 
more soluble expression was achieved. While when using both PEG8000 and choline at the optima 
concentrations, an increase of around 60% was obtained. This 60 % increase was much more than 
simply sum up of the 17% and 23%. Which might indicate an additional beneficial effect came from 
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the interaction of the two compounds. The successful application of the systematically screening of 
chemical stabilizers offered an example to use the automatic throughput CF platform. 
Preliminary studies on the application of the established throughput CF platform on MPs 
were performed. We choose the D-CF mode for directly soluble expression of MPs in this platform. 
However, one challenge was to find a monitor to characterize the expression and even the folding of 
expressed MPs. Taken the idea from in vivo expression system for MPs, which use a C-terminal 
GFP fusion for the fast detection of soluble expressed MPs in either E. coli or yeast expression 
system. The same approach was used in this CF system. By following the fluorescence of the fused 
sGFP, the soluble expression of MPs can be detected and quantified. Since detergents was used to 
provide hydrophobic environment for MPs, the folding of GFP in presence of detergents needs to be 
evaluated. However, results showed that the folding of normal sGFP was highly influenced by 
detergents. sGFP only gave relative high fluorescence accounts in limited detergents like Brij 
derivatives. With the best detergent, less than 60% sGFP was folded compared to the control 
without detergent. With other commonly used detergents like Digitonin, TritonX-100 and DDM 
very low fluorescence signals were detected, indicating that sGFP was poorly folded in these 
detergents. The limitation of choosing detergents reduced the application this method for many MPs 
because many MPs cannot be soluble expressed with the Brij detergents. In order to solve this 
problem, a mutant of GFP was selected, which was called superfolderGFP. This superfolderGFP 
was super stable, less affected by the out environment and fast folding compared to normal sGFP. A 
comparison experiment of detergent screening was performed with both sGFP and superfolderGFP 
showed that in general the superfolderGFP had a better detergent tolerance. Those detergents like 
TritonX-100, Digitonin and DDM can allow the folding of superfolderGFP to more than 70%. With 
Brij-78 the fluorescence was almost the same compared to the control. Furthermore, a MP SugE 
(small multidrug transporter) was selected as an example for detergent screening. Result showed 
that SugE fused with superfolderGFP gave relative good fluorescence signal in Brij-78, Brij-58, 
Digitonin and Lauryl-MNG. With Brij-58, the fluorescence was even higher than Brij-78. These two 
experiments showed that with superfolderGFP more detergents can be select for D-CF expression of 
MPs fusion partners. Introducing the superfolderGFP as fusion monitor increases the application of 
the throughput CF platform in detergents screening for MPs. Further experiment with detergents and 
lipids mixture provide another promising tool for obtain soluble MPs with functions. However, 
more research still need to be done to provide more information about the ratio of lipid/detergents in 
practical applications. 
Two different MPs, SugE (small multidrug transporter from E. coli), AQP4 M23 (aquaporin 
4 from mouse), were selected and studied. The sample preparation of SugE, offered a new approach 
for obtain pure, homogeneous and stable MP protein sample. SugE was expressed in CF system first 
as precipitate and later on re-solubilized with detergent. A two-step re-solubilization strategy was 
applied. First treat the protein pellet from the reaction with relative mild detergent like NDSB256. 
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Second, re-solubilize the remaining pellet with DDM. The first step, the mild detergent will 
solubilize quite a lot of impurities not the target protein SugE. In the second step, DDM will 
solubilize most of the SugE protein and small amount of impurities. With this two-step re-
solubilization approach, without any chromatography approach, the sample was already relative 
pure. Later on with another SEC, the sample was purified as one pure band on SDS-PAGE and 
showed homogeneous elution profile on the gel filtration column. Later on, in order to obtain more 
detergent conditions which can keep SugE homogeneous and stable, a detergent exchange was 
performed directly on the SEC column. Detergents with different micelle size were selected and 
some of them also showed comparable elution profile of DDM.  
Another MP we selected was AQP4 M23. The mouse aquaporin 4 was selected as a 
representative of mammalian aquaporins. The protein was synthesized in an E. coli extract based CF 
system with two different expression modes, and the efficiencies of two modes were compared. In 
both, the P-CF (CF MP expression as precipitate) mode generating initial aquaporin precipitates as 
well as in the D-CF (CF MP expression in presence of detergent) mode, generating directly 
detergent solubilized samples, we were able to obtain mg amounts of protein per ml of CF reaction. 
Purified aquaporin samples solubilized in different detergents were reconstituted into liposomes, 
and analyzed for the water channel activity. The calculated Pf value of proteoliposome samples 
isolated from the D-CF mode was 133 µm/s at 10
o
C, which was 5 times higher as that of the control. 
A reversible inhibitory effect of mercury chloride was observed, which is consistent with previous 
observations of in vitro reconstituted aquaporin 4. In this study, a fast and convenient protocol was 
established for functional expression of aquaporins, which could serve as basis for further 
applications such as water filtration. 
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Zusammenfassung 
 
In der postgenomischen Ära werden Proteomstudien attraktiver und helfen dabei die in den 
Genen verborgene Information zu entschlüsseln. Jedoch erfordern Proteomstudien die Synthese 
größerer Proteinmenge oder Proteinanzahl. In den letzten Jahrzehnten wurde die heterologe 
Überexpression von rekombinantem Protein in Bakterien, Hefe, Insektenzellen und Säugetierzellen 
entwickelt. Mit dem E. coli System, welches am besten untersucht ist, ist man in der Lage, gänzlich 
verschiedene rekombinante Proteine sowohl prokaryotischen als auch eukaryotischen Ursprungs zu 
erhalten. Nichtsdestotrotz gibt es eukaryotische Proteine die im bakteriellen System nicht 
funktionell aktiv exprimiert werden können. Diese können oft mit Hilfe von eukaryotischen 
Expressionssystemen wie Hefe, Insektenzellen oder Säugetierzellen hergestellt werden. 
Eukaryotische Überexpressionssysteme erfordern jedoch komplexere Verfahren und es erfordert 
einen zeitaufwendigen Prozess um letztendlich das rekombinante Protein zu erhalten. Das zellfreie 
(CF) Expressionssystem nutzt Zelllysate welche die Maschinerie für Transkription, Translation, 
zusätzliche Energieressourcen und Substrate für die Proteinsynthese enthält. Das CF System wurde 
als erstes dazu genutzt um den genetischen 'Code' durch in-vitro Translation von Poly-U RNA 
Sequenzen zu entdecken. Erst später wurde die Methode weiterentwickelt um Proteine zu 
synthetisieren, zog mehr Aufmerksamkeit auf sich und etablierte sich als alternative Methode neben 
den konventionellen zellulären Expressionssystemen. 
Der Verzicht auf die Nutzung lebender Zellen macht das CF Expressionssystem offen für 
eine Vielzahl an Modifikationen. Es kann eine breitere Anwendung finden, insbesondere in der 
Expression von schwierigen Untersuchungsobjekten wie Toxinen, Membranproteinen (MPs), 
unlöslichen oder aggregationsgefährdeten Proteinen, welche in konventionellen in-vivo 
Expressionssystemen nicht hergestellt werden können. Die offene Natur und die Verbesserung der 
Hochdurchsatz-Automatisierung machte das CF System zu einem idealen System für die 
Proteomforschung. In dieser Arbeit wird versucht eine Hochdurchsatz-CF Expressionsplattform zu 
entwickeln, die schwierigen Untersuchungsobjekten einschließlich Membranproteinen und 
aggregationsgefährdeten Proteinen gerecht wird. 
Um eine Hochdurchsatzplattform zu etablieren wurde ein CF 'Batch' Expressionssystem 
ausgewählt, welches relativ einfach gehandhabt werden kann und zeitsparend ist. Die relativ 
niedrige Expressionsausbeute kann durch sensitivere Detektionsmethoden ausgeglichen werden. Mit 
dem TECAN Freedom EVO 200 'liquid handling' Roboter wurde eine volle Automatisierung des CF 
Expressionssystems erreicht. Die Plattform ermöglicht die schnelle, parallele CF Expression von bis 
zu 96 Reaktionen in einem Minimalvolumen von 25 µl. Die komplette Expression dauert 2-4 
Stunden und erreichte eine Ausbeute von 0.5 bis 1 mg pro mL Reaktionsmixtur. Die speziell 
entworfene Software E.Y.E.S stellt eine vielfältige und nutzerfreundliche Umgebung für den 
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Hochdurchsatzscreen von CF-Expressionen zur Verfügung. Das E.Y.E.S Programm reduzierte die 
Zeit für das Programmieren und Pipettieren des Roboters in hohem Maße. Die gesamte Pipettierzeit 
für 96 Reaktionen wurde auf 30-45 Minuten reduziert. Mit Hilfe dieser robotergestützten Plattform 
kann die Optimierung von Expressionsbedingungen mit Fluoreszenz-Detektion durch Fusion von 
grün fluoreszierendem Protein (GFP) an das zu untersuchende Protein kombiniert werden. 
Mittels dieses etablierten Hochdurchsatz CF Expressionssystems kann der Effekt von 
gängigen chemischen Stabilisatoren auf das CF System untersucht werden. 'shifted GFP' (sGFP) 
wurde als das zu untersuchende Protein gewählt. Zunächst wurde die Kompatibilität der selektierten 
chemischen Stabilisatoren mittels Fluoreszenz von CF exprimierten sGFP evaluiert. Mit diesen 
Experimenten können die Effekte der selektierten chemischen Stabilisatoren in drei Klassen 
eingeteilt werden: positiv, negativ und tolerant. Ein positiver Effekt eines selektierten Stabilisators 
hatte eine Erhöhung der Fluoreszenz von sGFP zur Folge. Ein negativer Effekt impliziert dass die 
selektierte chemische Verbindung toxisch auf die CF Expression wirkt und die Expression inhibiert. 
Ein toleranter Effekt bedeutet dass die Expression von sGFP im CF System linear mit zunehmender 
Konzentration der chemischen Verbindung abnimmt. Die Stabilisatoren welche einen positiven oder 
toleranten Effekt auf das CF Expressionssystem haben, können genutzt werden um die Löslichkeit 
und Stabilität von instabilen oder aggregationsgefährdeten Proteinen zu erhöhen, sobald sie 
exprimiert worden sind. Um die Anwendung von chemischen Stabilisatoren beurteilen zu können, 
haben wir zwei Proteine ausgewählt: Das GNA1 (EC 2.3.1.4)  katalysiert den Transfer einer 
Acetylgruppe vom AcetylCoenzymA (AcCoA) auf das primäre Amin von D-Glucosamin-6-
phosphat mit den Nebenprodukten N-acetyl-D-Glucosamin-6-phosphat (GlcNAc-6P) und Coenzym 
A (CoA). Die Halogenase ist das erste Enzym in der Biosynthese von Curacin A (CurA, eine 
bioaktive Verbindung mit potenter anit-proliferativer Aktivität). Die Biosynthese von CurA wird 
durch die 2.2 MDa große Hybridpolyketidsynthase (PKS) und nicht-ribosomale Peptidsynthetasen 
(NRPS) durchgeführt. Beide werden teilweise löslich in-vivo bzw. in-vitro exprimiert. Verschiedene 
chemische Stabilisatoren wurden selektiert um die Möglichkeit einer verbesserten löslichen 
Expression im CF System zu testen. Im Fall der Halogenase wurde eine um 25% erhöhte Expression 
mit Cholin beobachtet. Auch im Fall von GNA1 wurde ein zuträglicher Effekt von Cholin 
beobachtet. sGFP wurde an den C-Terminus von GNA1 fusioniert, um zu testen ob die Amplitude 
des Fluoreszenzsignals mit der Funktion des Fusionspartners korreliert ist. Es zeigte sich dass die 
Funktion nicht vollständig mit dem Fluoreszenzsignal von sGFP korreliert. Im Fall von L-Arginin 
erhöhte sich die Fluoreszenz des Fusionsproteins ohne einen Anstieg der Funktionalität von  GNA1. 
Dies lässt sich durch einen positiven Effekt auf die Faltung von sGFP erklären. Schlussendlich 
wurden PEG 8000 und Cholin ausgewählt, um ein Beispiel eines korrelierten Effekts von zwei 
chemischen Verbindungen zu zeigen. PEG 8000 alleine erhöhte die lösliche Expression um 17% 
während Cholin eine 23% höhere Expression bewirkte. Im Kontrast dazu erhöhte die Zugabe von 
beiden Verbindungen bei optimierter Konzentration die lösliche Expression um 60 %. Diese 
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60 %ige Zunahme war mehr als einfach die Summe von 17 % und 23 % was dafür spricht, dass der 
positive Effekt aus einer Interaktion der beiden Verbindungen resultiert. Die erfolgreiche 
Anwendung des 'Screenings' nach chemischen Stabilisatoren ermöglichte ein Anwendungsbeispiel 
für die vollautomatische CF-Hochdurchsatzplattform. 
Vorläufige Studien bezügliche der Anwendung der etablierten Hochdurchsatzplattform auf 
Membranproteine (MP) wurden durchgeführt. Der D-CF Modus wurde für die direkte lösliche 
Expression von MPs gewählt. Eine Herausforderung war es einen Weg zu finden, die Expression 
und die Faltung von MPs verfolgen zu können. Das Verfahren welches bei der in-vivo Expression 
von MPs genutzt wird, nämlich die C-terminale Fusion an sGFP zur schnellen Detektion von MPs 
aus E. coli oder Hefe, wurde für das CF System übernommen. Über die Fluoreszenz des fusionierten 
sGFP wird die lösliche Expression von MPs detektiert und quantifiziert. Da Detergenzien genutzt 
wurden um den MPs eine hydrophobe Umgebung zu geben, musste die Faltung von sGFP in 
Anwesenheit von Detergenzien evaluiert werden. Die Faltung von sGFP zeigt sich sehr stark 
beeinflusst durch die Detergenzien. Ein relativ hohes Fluoreszenzsignal wurde lediglich für Brij-
Derivate beobachtet. Im besten Fall waren weniger als 60% GFP im Vergleich zur Kontrolle ohne 
Detergenz gefaltet. Häufig genutzte Detergenzien wie Digitonin, TritonX-100 und DDM führten zu 
einem geringeren Fluroeszenzsignal, implizierend dass sGFP in diesen Detergenzien in 
geringfügigen Ausmaß faltet. Die Einschränkung der Detergenzwahl schränkte die Anwendung der 
Methode für viele MPs ein, da diese in Brij-Detergenzien oft nicht löslich gehalten werden können. 
Um dieses Problem zu lösen wurde eine GFP-Mutante ausgesucht, das sogenannte 
'‘superfolderGFP’'. Dieses ist extrem stabil, weniger durch seine Umgebung beeinflusst und faltet 
schneller als normales sGFP. Ein Vergleichsexperiment zeigte dass ‘superfolderGFP’ generell 
Detergenz-toleranter als sGFP ist. In TritonX-100, Digitonin und DDM ist ‘superfolderGFP’ zu 
mehr als 70% gefaltet. In Brij-78 zeigt  ‘superfolderGFP’ ein fast identisches Fluoreszenzsignal im 
Vergleich zur Kontrolle. Das Membranprotein SugE wurde als Beispiel für einen 'Detergenzscreen' 
gewählt. SugE fusioniertes ‘superfolderGFP’ zeigt ein relativ gutes Fluoreszenzsignal in Brij-78, 
Brij-58, Digitonin und Lauryl-MNG. Brij-58 zeigt sogar ein höheres Fluoreszenzsignal als Brij-78. 
Diese beiden Experimente zeigten, dass mit ‘superfolderGFP’ mehr Detergenzien für die D-CF 
Expression von MP-Fusionspartnern ausgewählt werden können. Dies erhöht die Anwendung der 
Hochdurchsatzplattform für das 'Screening' von Membranproteinen in Detergenzien enorm. Auch 
die Zugabe von Detergenz- und Lipidmixturen ermöglicht die lösliche und funktionelle Expression 
von MPs. Jedoch ist mehr Wissen über das optimale Lipid/Detergenz-Verhältnis für die praktische 
Anwendung nötig.   
Zwei Membranproteine wurden für diese Arbeit ausgewählt und studiert: SugE ('small 
multidrug transporter' aus E. coli) und AQP4 M23 (Aquaporin 4 aus der Maus). Die Präparation von 
SugE eröffnete einen neuen Weg um reines, homogenes und stabiles MP zu erhalten. SugE wurde 
im CF System als Präzipitat exprimiert und später mit einem Detergenz resolubilisiert. Diese 
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Resolubiliserung wurde in zwei Schritten durchgeführt. Als erstes wurde das Pellet mit einem 
relativ milden Detergenz wie NDSB256 behandelt, welches somit Verunreinigungen durch 
Resolubilisierung entfernt. Als nächstes wurde SugE sowie eine geringe Menge an 
Verunreinigungen mit DDM resolubilisiert. Mittels dieser zweistufigen Resolubilisierung wird ohne 
Anwendung eines Chromatographie-Schritts bereits eine relativ reine Probe erhalten. Eine folgende 
Größenaufschlusschromatographie zeigte ein homogenes Elutionsprofil sowie eine einzelne Bande 
auf einem SDS-PAGE (Natriumdodecylsulfat-Polyakrylamid Gelelektrophorese) Gel. Um die finale 
Ausbeute zu maximieren wurden verschiedene Detergenzien getestet, welche das SugE homogen 
und stabil halten. Detergenzien mit unterschiedlicher Mizellengröße wurden ausgewählt und zeigten 
ähnliche Elutionsprofile im Vergleich zu DDM. 
Das Aquaporin 4 (AQP4 M23) aus der Maus wurde als Repräsentant für Aquaporine aus 
Säugetieren zu Studien selektiert.  Das Protein wurde in einem E. coli Extrakt-basierten CF System 
in zwei Expressionsmodi synthetisiert und deren Effizienz wurde verglichen. Im P-CF (zellfreie 
Membranproteinexpression als Präzipitat) sowie im D-CF (zellfreie Membranproteinexpression in 
der Anwesenheit von Detergenz) Modus in welchen Aquaporin als Präzipitat bzw. direkt in 
Detergenzien gelöst vorliegt, wurde das Protein im Milligrammmaßstab pro mL Zell-frei Reaktion 
erhalten. Gereinigte Aquaporinproben wurden in verschiedenen Detergenzien gelöst, in Liposomen 
rekonstituiert und auf ihre Wasserkanalfunktionalität hin analysiert. Der berechnete Pf-Wert von 
Proteoliposomproben aus dem D-CF Modus betrug 133 µm/s bei 10°C, und liegt damit um den 
Faktor 5 höher als die Kontrolle. Ein reversibler inhibitorischer Effekt von Quecksilberchlorid 
wurde beobachtet, welcher konsistent mit früheren Untersuchungen von in-vitro rekonstituiertem 
Aquaporin 4 ist. In dieser Studie wurde ein schnelles und geeignetes Protokoll zur funktionellen 
Expression von Aquaporinen erstellt, welches als Basis für weitere Anwendungen wie z.B. der 
Wasserfiltration dienen kann. 
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1. Introduction 
MPs act as the link between the cytoplasm and the cellular environment. Essential cell 
processes like signal transmission, transport of substances through the membrane, generation of 
energy are associated with MPs. Therefore, many drugs are designed against MPs, which become 
important targets for medical and pharmaceutical studies. However, a major bottle neck for study 
MPs is the limitation in sample preparation. Traditional in-vivo expression system was well 
established, especially the bacterial Escherichia coli expression system, for producing recombinant 
proteins. However, in-vivo expression system based either on prokaryotic or eukaryotic cells do not 
work for the MPs production. The same difficulty also appears when try to express other 
problematic proteins like, toxins, instable enzymes, aggregation prone proteins. The toxic effect on 
the host cells, when producing MPs and other problematic proteins, always results in low expression 
yield and forming aggregation or unfolded state. 
CF expression systems have been developed in recent times as alternative and promising 
tools to address the challenge of producing MPs and other problematic targets. The open nature and 
elimination of living host cells during protein expression offers a variety of advantages. It is proved 
that the toxic or inhibitory effects via recombinant MPs, toxins and other problematic proteins are 
minimized or even completely eliminated. Remove of the cell wall and membrane barrier gave the 
open nature of the CF expression systems. Additional compounds can be directly introduced into the 
system without the concern of transport and metabolic conversion problems. Additional protease 
inhibitors, ligands, cofactors or chemical stabilizers can be used as additives that might be helpful to 
stabilize and folding of the freshly expressed proteins. This characteristic of CF expression system 
provides a flexible and changeable environment for different targets. In the case of MPs, MPs can 
be expressed in the soluble form by offering an artificial hydrophobic environment via using 
detergent micelles, liposomes or nanolipoprotein particles. In case of instable and aggregation prone 
soluble proteins, additional chemical stabilizer can be introduced into the CF system as stabilizer to 
hold the correct folding of expressed proteins. Furthermore, CF reactions are often carried out in a 
small volume from a few milliliters to microliters and require only short incubation time of a few 
hours. High expression yield of several milligrams of proteins can be obtained per milliliter of 
reaction. With all the advantages above, CF expression system draws great attention for its 
application in preparative scale protein production, throughput screening and proteome studies. 
1.1 Membrane proteins 
    MPs are attached to, or associated with, biological membranes. They consist 20-40% of 
all open reading frames in fully sequenced genomes and are targets of around 60% of all modern 
drugs. Human genome analysis in 2002 led to estimation of 6000-8000 targets of pharmacological 
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interest. Only a small part of these targets relate to approved drugs. A consensus number of 324 
drug targets for all classes of approved therapeutic drugs was proposed [2]. Of these, 266 are human 
genome-derived proteins, and 58 are bacterial, viral, fungal or other pathogenic organism targets. 
The analysis by Overington et al. identifies in excess of 21 000 drug products marketed in US 
corresponding to 1357 unique drugs, of which 1204 are ‘small-molecule drugs’ and 166 are 
‘biological drugs’. 27% of these drugs bind to G-protein-coupled receptors (GPCRs; ~20 families, 
each family including up to five members), 13% to nuclear receptors, 7.9% to ligand-gated ion 
channels and 5.5% to voltage-gated ion channels. A selected target may have a unique approved 
drug, or a large number of me-too molecules. This draws great attention for researchers to study 
MPs in view of their fundamental role in all biological processes and for finding new targets for 
therapies. 
1.1.1 Water channel proteins 
Water is the most abundant and basic molecule in cell. The cell separates itself by the 
plasma membrane, which has a basic structure of phospholipid bilayer. The phospholipid bilayer is 
permeable to small molecule, and water can diffuse slowly through the membrane. However, there 
is a type of integral MP, which forms as a channel to facilitate the passing of water across the 
biomebranes. Such water channel proteins have been found in organisms from bacteria to plant and 
animals, named aquaporins (AQPs)[3]. AQPs are integral MPs that serve as channels in the transfer 
of water, and in some cases, small solutes across the membrane. They are conserved in bacteria, 
plants, and animals. Structural analyzes of the molecules have revealed the presence of a pore in the 
center of each aquaporin molecule. Since multiple isoforms of aquaporins are differentially 
expressed in cells and tissues, understanding of different roles of each AQP isoform therefore 
become important.  
In human, 13 different and tissue specific AQPs are responsible for transport mechanisms 
and showed considerable clinical relevance[4]. Among them, AQP4 is known as a water-
transporting aquaporin with two isoforms differing from their N-termini, which result from variable 
translation starting sites either from methionine M1 (323 aa) or methionine M23 (301 aa) [5]. AQP4 
is found in many organs and tissues like kidney, skeletal muscle, stomach, lung, air epithelium and 
brain. Phenotype analysis of AQP4-knockout mice indicated its involvement in the brain water 
balance [6]. AQP4 expression was furthermore shown to be induced during spongiform 
encephalopathy [7], neuromyelitis optica, multiple sclerosis [8], and Alzheimer’s disease [9]. In 
addition, AQP4 provides a molecular pathway for water permeability and homeostasis in the brain, 
and its astrocytic end-feet localization makes AQP4 a partner to blood-brain-barrier function [10]. 
Sufficient amounts of protein have been obtained for 2D crystallization and functional 
characterization of rat AQP4 [11]. Nevertheless, the purification processes are time-consuming and 
the yield with approx. 3 mg/l produced in insect cells [11] is still not satisfying if compared with 
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that of soluble proteins. Further biochemical and biophysical characterizations as well as high-
throughput research towards the relationship between aquaporin and certain diseases remain 
therefore to be difficult. Recently, an increasing interest is to prepare some functional 
biomembranes integrated with bioactive AQPs to filtrate water [12]. However, the success of this 
amazing strategy largely depends on the availability of sufficient and functional AQPs, which still 
remains challenging [13, 14]. 
1.1.2 Transporters- multidrug resistance efflux pumps 
The number of antibiotics to which bacteria have developed resistance has increased greatly, 
during the last decade. Therefore, the problem of inefficient antibiotics for treatment of infections 
became a big challenge. Another concern is about the increase number of bacteria, which is 
becoming resistant to more than one antibiotic. Efflux-pump genes and proteins are present in 
nearly all organisms. In bacteria, the genes that encode efflux pumps are located on the chromosome 
or on transmissible genetic elements, such as plasmids. It is well known that, in bacteria, efflux 
pumps can confer decreased susceptibility to antibiotics; however, such decreases do not always 
result in clinical levels of antibiotic resistance. Efflux pumps can be specific for one substrate or can 
transport a range of structurally dissimilar compounds (including antibiotics of different chemical 
classes). Those pumps that transport several compounds can be associated with multidrug (antibiotic) 
resistance (MDR). Many of these efflux pumps are therefore of clinical relevance because they can 
render a bacterial infection untreatable by the agent(s) of choice [15]. MDR mediate by specialized 
multidrug efflux transporters, which contain several different protein super families. They are the 
ATP binding cassette (ABC) superfamily, the major facilitator superfamily (MFS), the multidrug 
and toxic-compound extrusion (MATE) family, the small multidrug resistance (SMR) family and 
the resistance nodulation division (RND) family as shown in Fig. 1.  MDR efflux pumps are 
classified as belonging to these families on the basis of the number of components that the pump has 
(single or multiple), the number of transmembrane-spanning regions that the transporter protein has, 
the energy source that the pump uses and the types of substrate that the pump exports. A single 
organism can express MDR efflux pumps from more than one family and/or more than one type of 
efflux pump belonging to the same family. 
For instance, Pseudomonas aeruginosa can express more than one type of Mex efflux pump, 
and E. coli can express more than one type of Acr efflux pump (both of which are pumps belonging 
to the RND family). Efflux pumps can consist of either a single component or multiple components. 
Examples of efflux pumps from each family are shown in Fig.1 
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Figure 1. Multidrug-resistance efflux pumps. There are five 
families of multidrug-resistance efflux pumps: the ATP-binding 
cassette (ABC) superfamily, the major facilitator superfamily 
(MFS), the multidrug and toxic-compound extrusion (MATE) 
family, the small multidrug resistance (SMR) family and the 
resistance nodulation division (RND) family. A diagrammatic 
representation of the structure and membrane location of efflux 
pumps from each of these families is shown. Common examples of 
the individual proteins that form each class of efflux pump are 
indicated. Antibiotic substrates and examples of other substrates 
are also listed for each class of efflux pump. Multidrug-resistance 
efflux pumps expressed by Gram-negative bacteria usually have 
several components, and the outermembrane protein is typically 
TolC. Pi, inorganic phosphate [15]. 
 
Efflux pumps, which belong to RNA family, 
often expressed by Gram-negative bacteria, are 
associated with clinically important MDR. They are 
organized as tripartite systems (Fig. 1). These efflux 
pumps comprise of a transporter (efflux) protein (i.e. 
AcrB), which is located in the inner (cytoplasmic) 
membrane of bacteria; an accessory protein (known as 
a membrane-fusion protein, i.e. AcrA); and an outer-
MP (also known as an outer-MP channel) (i.e. TolC) 
[16], which is located in the outer membrane of the 
bacterium. Using the AcrAB-TolC system (that is, the 
efflux pump comprising AcrA, AcrB and TolC) as an 
example, it is thought that the transporter protein AcrB, 
similar to AcrD [17], captures its substrates either 
from the phospholipids bilayer of the inner membrane 
or from the cytoplasm, and then transports them to the 
extracellular medium through TolC, which forms a 
channel in the outer membrane[18]. The cooperation 
between AcrB and TolC is mediated by the 
periplasmic accessory protein AcrA. Efflux through 
RND-family pumps is driven by the proton motive 
force [18], an electrochemical gradient in which the 
movement of hydrogen ions drives transport of the substrate. In Enterobacteriaceae, TolC function 
as the protein channel for different RND-family efflux pumps, and it can also interact with MFS 
transporters (for instance, EmrAB of E. coli) and ABC-superfamily transporters (for instance, 
MacAB of E. coli). Similarly, the RND-family outer-MP OprM of P. aeruginosa can interact with 
several RND-family proteins. 
Introduction 
 
-16- 
 
1.2 Aggregation and inclusion body - aggregation prone proteins 
Protein aggregation is an inevitable result of cellular existence. Protein aggregates are 
oligomeric complexes of non-native conformers that arise from non-native interactions among 
structured, kinetically trapped intermediates in protein folding or assembly [19-21] (Fig. 2). Protein 
aggregation is facilitated by partial unfolding during thermal or oxidative stress and by alterations in 
primary structure caused by mutation, RNA modification or translational misincorporation [20, 22]. 
Protein aggregates can be either structured (e.g. amyloid; Fig. 2a) or amorphous (Fig. 2b). In both 
case, they are prone to behave insoluble and metabolically stable under physiological conditions. 
The accumulation of aggregation is tightly linked to neuronal degeneration or organ failure in many 
‘protein deposition’ diseases. The fact that protein aggregates do not accumulate in unstressed cells, 
despite their continued production, is due in part to the existence of cellular ‘quality control’ 
machinery. This suppresses the formation of aggregates by ensuring the fidelity of transcription and 
translation, by chaperoning nascent or unfolded proteins, and by selectively degrading improperly 
folded polypeptides before they can aggregate [23, 24]. The prominence of protein aggregates in 
intracellular and extracellular lesions associated with cell death in many degenerative diseases (e.g. 
amyloid diseases, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and alcoholic 
liver disease [25]) underscores the physiological importance of these quality control pathways and 
suggests that the failure of these systems to control aggregation might have catastrophic 
consequences for the organism. However, protein aggregation need not be pathogenic. For example, 
in yeast, cytoplasmic inheritance of aggregated prion proteins underlies the propagation of stable 
epigenetic traits that are not associated with any known pathology [26]. Although considerable 
research has addressed the mechanisms by which cells avoid forming protein aggregates, the way 
that cells deal with proteins once they have aggregated is relatively unexplored. 
With the development of heterogeneous expression system, scientists are able to over 
express heterogeneous proteins in other host cells as recombinant proteins. The enteric bacterium E. 
coli is one of the most extensively used prokaryotic organisms for genetic manipulations and for the 
industrial production of proteins of therapeutic or commercial interest. Compared with other 
established and emerging expression systems[27], E. coli offers several advantages, including 
growth on inexpensive carbon sources, rapid biomass accumulation, amenability to high cell-density 
fermentations and simple process scale-up. It is, however, not uncommon that overexpressed 
recombinant proteins fail to reach a correct conformation and undergo proteolytic degradation or 
associate with each other to form insoluble aggregates of nonnative proteins known as inclusion 
bodies. 
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Figure 2. Protein aggregates arise from 
kinetically trapped products of protein 
folding or degradation. (a) Formation of 
structured aggregates. The overall 
efficiency of protein folding is the 
proportion of intermediate that assumes a 
native conformation. Intermediates can 
also assume misfolded, off-pathway 
conformations, which are prone to 
oligomerize into non-native aggregates. 
The ubiquitin–proteasome pathway 
competes for and degrades off-pathway 
intermediates before they can aggregate. 
(b) Misfolded integral membrane and 
secretory proteins are dislocated across the 
endoplasmic reticulum (ER) membrane to 
the cytoplasm for degradation by the 
ubiquitin-proteasome pathway. Such 
dislocated intermediates might be highly 
aggregation prone in the aqueous, 
reducing, environment of the cytoplasm. 
The proportions that are degraded and that 
aggregate are determined by the relative 
rates of proteasomal degradation and 
aggregation, and by the degree of coupling 
between dislocation and degradation[28]. 
 
For a heterologous protein, 
failure to rapidly reach a native 
conformation or to interact with 
folding modulators in a timely 
fashion has two possible 
consequences: partial or complete 
deposition into insoluble 
aggregates known as inclusion bodies or degradation. The likelihood of misfolding is increased by 
the routine use of strong promoters and high inducer concentrations that can lead to product yields 
exceeding 50% of the total cellular protein. Under such conditions, the rate of protein aggregation is 
often much greater than that of proper folding and folding modulators are rapidly titrated. A second 
factor contributing to inclusion body formation is the inability of bacteria to support all post-
translational modifications that a protein requires to fold. For instance, the formation of intra- or 
intermolecular disulfides is not possible in the reducing cytoplasm of wild-type E. coli, which 
results in the aggregation of certain disulfide bond-rich proteins (e.g., Fab antibody fragments). 
Inclusion bodies can accumulate in the cytoplasm or periplasm depending on whether or not 
a recombinant protein has been engineered for secretion. The target typically accounts for 80-95% 
of the inclusion body material and is contaminated by outer MPs, ribosomal components and a small 
amount of phospholipids and nucleic acids that likely adsorb upon cell lysis [29]. Folding 
modulators (e.g., DnaK, GroEL and IbpA/B) are sometimes-but not always-associated with 
inclusion bodies [30, 31]. Cytoplasmic inclusion bodies are porous ovoids or cylinders with 
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maximum characteristic length and volume of 1 μm and 0.6 μm [32], respectively [31, 33, 34]. 
However, hemispherical inclusion bodies of 0.5-μm diameter have been observed in the periplasm 
[33]. In the cytoplasm, inclusion bodies grow from structured folding intermediates9 at nearly 
constant rates and around nucleation cores that are mutually exclusive. Thus, multiple inclusions of 
different sizes may be present within a single cell [31]. Because inclusion bodies are resistant to 
proteolysis and contain large amounts of relatively pure material, their formation is often exploited 
for the production of proteins that are toxic, unstable or easy to refold. Finding optimal conditions 
for efficient refolding requires considerable optimization, but acceptable yields can usually be 
achieved using established strategies [35]. 
1.3 Systems for expressing challenging protein targets 
Lot of researches has been done to optimize the expression yield and quality of challenging 
targets like aggregation prone proteins, toxins and especially MPs. In each step of expression, there 
can be potential improvement. For instance, the design of suitable vector (e.g. include fusion 
partners for target protein to improve the solubility and folding), cultivation conditions (usage of 
special chemical compound in the media, control the cultivate temperature and so on), expression 
strategies. It is especially hard for expression MPs in a soluble and correctly folded state.  The 
hydrophobic characteristic of MPs results in non-soluble and aggregated protein during 
overexpression. 
1.3.1 Conventional in-vivo expression systems 
Selection of suitable expression system is crucial for the successful expression of proteins. 
It is always the first choice to look for the organism, in which certain target is naturally abundant. 
Then, this organism can be used to over produce certain abundant protein or related proteins. 
However, due to the fact that not all the organisms have well established expression strategies, it is 
often the case that one has to choose another easy handle host for heterogeneous expression. 
Few elaborated, well-documented and studied system like E. coli, yeast, insect cells and 
mammalian cells are therefore prevalent for challenging protein production. There are various 
modifications of those expression systems, which give better production for difficult targets (e.g. 
MPs). Those well established and reliable protocols often give the first idea to overcome the 
difficulty of expression. For instance, E. coli is frequently the first and only choice for prokaryotic 
proteins, while eukaryotic proteins are often attempt to be produced in prokaryotic as well as in 
eukaryotic backgrounds.  
Take MPs as example to handle challenging targets. Central factors that could determine the 
yield, integrity, activity and stability of synthesized MPs are the availability of highly processive 
transcription and translation machineries, suitable folding environments, the lipid composition of 
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cellular membranes, the presence of efficient targeting systems and appropriate pathways for 
posttranslational modifications (PTMs). Strong biases between the codon usage of the target gene 
and the host`s translation machinery could result in premature termination of the polypeptide chain 
or in mis-incorporation of amino acids, both having severe effects on sample quality and 
functionality of the final MPs [36, 37]. Most PTMs of recombinant eukaryotic MPs are unlikely to 
occur in prokaryotic expression hosts such as E. coli and Lactococcus lactis, which sometimes may 
hamper functional folding but in other cases could be beneficial for crystallization studies. In 
addition, bacterial MPs typically have a cytoplasmic location for both the N as well as the C-
terminus [38]. The prevalent requirement of an N-terminus-out topology for eukaryotic MPs like G-
protein-coupled receptors (GPCRs) could therefore cause problems in correct targeting and 
membrane insertion.  
Specific lipids or hydrophobic environments can play important roles in the functional 
folding or stabilization of MPs [39, 40]. Many crystallized MP complexes show defined protein-
lipid contacts. Especially sterol derivatives such as cholesterol appear to influence the function of 
distinct mammalian MPs. Also, folding and function of bacterial MPs can depend on the presence of 
specific lipids, as reported for the lactose permease in E. coli [41]. Most observed lipid effects on 
MPs are still difficult to interpret. They could result from altered membrane properties like changes 
in fluidity, bilayer thickness and lateral pressure, from positioning MPs in correct orientations 
within the membrane or from structural stabilization by direct lipid-MP interactions. While 
specificity could be shown in some cases, it is not clear for many identified interactions whether 
they are promiscuous and whether the lipids could be replaced by other structurally similar 
compounds. The lipid composition of host cells from the different expression systems varies 
considerably, and an overview is given by [40]. Bacterial membranes are generally devoid of sterols, 
sphingolipids and polyunsaturated side chains, which are prevalent in eukaryotic membranes. 
However, insect cells also have much lower cholesterol levels compared with mammalian cells, and 
they completely lack phosphatidyl-serine. The selection of an expression system or cellular 
background should therefore be of major concern for the lipid composition of the host cell 
membranes in addition to specific codon usages and prevalent glycosylation patterns. Expression of 
MPs in cellular backgrounds as closely related to their origin as possible thus appears to be the most 
reasonable strategy. However, the efficiency and workload of the individual expression systems are 
quite different, and preparative amounts of MPs are often only obtained with bacterial, yeast 
systems. Therefore, compromises must be made, if no specific requirements for the synthesis, 
folding or transport of an MP is evident, heterologous expression even in unrelated backgrounds 
might still provide the greatest success, especially in view of obtaining higher yields. 
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1.3.2 Cell-free systems 
CF system is simply activating biological processes without a living cell. It is based on 
crude extracts, which provide low-cost catalyst and greater system compatibilities. CF biology has 
been used and developed for decades, mostly to study biological phenomena, and it was used first to 
decipher the genetic code 50 years ago [42]. For long time, the researchers were intimidated by the 
complexity of crude cell extracts containing hundreds of active biological catalysts. Recently, the 
‘black box’ has been illuminated by number of examples indicating that the reaction networks can 
be understood, changed, and controlled. CF technologies simplify and harness cellular biology and 
also utilize the entire reactor volume instead of the 5 to 20% volume fraction (the intracellular 
volume) that is used in a typical fermentation process. Importantly, CF approaches provide direct 
access to the complex set of chemical reactions that take place in a living cell. The process then 
takes on the form and function of chemical processes employing homogeneous catalysis; processes 
that have been practiced and improved by chemical engineers for decades. Two most important 
applications of CF system draw great attention of biologist to explore and use this technique. They 
are CF protein synthesis (CFPS) and CF metabolic engineering (CFME).   
The initial and well developed CF technology is CFPS. Extract from different source was 
used as the source of protein synthesis catalysts. In all cases, the cells are lyzed and the released 
content diluted. The dilution has effect on reducing the crowding effect in the cells. As a result, few 
or no background protein synthesis exists directed by the chromosomal DNA. The loosely 
associated sigma factors fall of the native RNA polymerase so that it is no longer functional to 
produce messenger RNA from the DNA remaining in the cell extract. For CFPS, however, 
monomolecular RNA polymerases such as those from the T7 and SP6 bacteriophages are added and 
function effectively with their respective promoters to produce only the desired mRNAs (and 
proteins).  
The dilution also appears to be beneficial for protein folding. Translational protein 
elongation is slowed to about 10% of its normal rate because of the lower concentrations of the 
required elongation factors. This allows more time for newly synthesized protein domains to fold 
before the following domains emerge from the ribosome. Also, since only one type of protein is 
being produced into the diluted solution, there is less chance for nascent, unfolded proteins to 
become tangled with each other. While the dilution may also reduce the effectiveness of chaperones, 
these can be overexpressed in the source cell before lysis, if required. Notably, the catalytic system 
will also be stabilized as the dilution also reduces the concentrations of proteases and nucleases. 
Amino acids are typically added to the lysate to serve as a major class of substrates, but 
protein synthesis is also one of the most energy demanding processes in typical cells. The entropic 
cost of assembling such precise macromolecules is high. This is another reason that expressing a 
single protein during CFPS is beneficial as chemical energy is not dissipated toward the synthesis of 
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undesired proteins. Most CFPS systems use a high-energy phosphate bond donor such as 
phosphoenolpyruvate (PEP), acetyl phosphate, or creatine phosphate, but newer systems activate 
normal aerobic catabolism to use glucose or glutamate as the energy source. The discovery that such 
complex metabolism could be activated and controlled in cell lysates has now sparked interest in 
using CF biology to produce important smaller biomolecules as well as proteins. 
CFME is an emerging area that is trying to take full advantage of the reaction accessibility 
offered by the CF approach. CF metabolic engineering methods provide unprecedented 
opportunities to monitor and control the entire metabolic system for maximal production rates and 
conversion efficiencies. 
1.3.2.1 Extract source for CF system 
As mentioned above, extract act as the pool of catalysts for CF systems for protein synthesis. 
There are extract from prokaryotic and eukaryotic organisms. The most well developed and 
characterized were the E. coli S30 extract and wheat germ extract. However, other sources like 
insect cells [43], rabbit reticulocyte [44], yeast [45], parasitic protozoan Leishmania tarentolae[46], 
human HeLa cells[47], Neurospora crassa [48], plant cells (liquid callus cultures of 
Arabidopsis)[49], are also developed to produce different recombinant protein from different 
organisms. However, E. coli and wheat germ extracts are still the most popular systems due to the 
easy availability and standardized protocols. The well-studied E. coli S30 extract is obtained by 
centrifugation of lyzed cells at 30,000g and it includes most enzymes necessary for protein synthesis 
[50, 51]. During the preparation, endogenous mRNA as well as low molecular weight compounds is 
eliminated from the extract. The normal procedure for S30 extract preparation consists of the 
following steps: fermentation of E. coli cells; harvesting and washing the cells; cell disruption via 
high pressure; clarification of the lysate by centrifugation at 30,000g; run off step; final dialysis 
against buffers. However, there are modifications of several steps, like using low centrifugation 
speed to get the so call S12 extract [52]; different treatment of the run off steps or totally run an 
empty run off step[53]; using different genetically modified E. coli strans [54]; and modifying the 
fermentation conditions [55, 56]. In a practical view, CF expression should be performed according 
to these published protocols [57, 58]. In addition, commercial kits are available for CF expressions 
from several companies. 
Besides the E. coli S30 extract, the wheat germ extract is also well studies and the 
preparation protocols are well established. Although the preparation and material availability are not 
as easy as E. coli extract, the advantage of eukaryotic background may offer better folding 
environment for certain eukaryotic targets. Generally, the wheat germ CF system is frequently 
operated as translation system with supplied mRNA as template, while the E. coli CF system is 
transcription and translation coupled system. The wheat germ CF reactions could be extended for 
even weeks with the final protein yields up to 10 mg/ml at optimal conditions [59]. Wheat germ 
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extracts are more difficult to prepare as the embryo is surrounded by the endosperm containing high 
levels of protein and nucleic acids degrading enzymes as well as translation inhibitors. In addition, 
high batch variations in extract quality of individually prepared extracts exist that depend on the 
origin of the wheat germs. However, commercial suppliers of wheat germ extracts or expression 
systems are available such as Cell Free Sciences Co. Ltd (Japan) or Roche Diagnostics. 
Further extract sources or alternative CF expression systems exist but only few have been 
used so far for the production of MPs. The PURE (Protein synthesis using recombinant elements) 
system represents a nearly complete reconstituted translation machinery of all aminoacyl-tRNA-
synthetases and translation factors that have been separately produced and purified from 
conventional in vivo E. coli expression [60, 61]. The ribosomes are still isolated from E. coli extract, 
but with a significantly higher purity after centrifugation at 100,000g. The PURE system allows CF 
synthesis under better defined conditions which can be advantageous for the study of folding 
pathways or translation kinetics. However, expression yields are lower if compared with other CF 
expression systems and it is only used for the analytical scale production of proteins. 
1.3.2.2 Template design 
In CF expression system, the template DNA has to be provided under control of specific 
and strong promoter sequence, most commonly recognized by phage polymerase like T7, SP6 or T3 
RNA polymerase. Several suitable vectors like pET (Novagen) or pIVEX (Roche Diagnostics) 
derivatives which contain the T7 promoter region are frequently used. The design of template in CF 
expression system to solve the expression of difficult targets seems very important. Frequent rare 
codons as well as unfavorable initiation of translation has been identified as major limiting steps in 
the protein synthesis [62, 63]. Secondary structures formation involving critical areas at the 5-prime 
end of the mRNA such as the ribosomal binding site could slow down or even prevent the initiation 
process [64-66]. Although algorithms have been established to optimize the DNA sequences to 
optimize the secondary structure of mRNA, it is still difficult to make reliable and efficient 
prediction of the mRNA structures due to its complexity. A high frequency of rare codons could 
cause the pause of translation, mis-incorporation of amino acids or even premature termination, but 
such problems could be solved by using codon optimized synthetic genes. 
Besides the traditional vectors which can be used as template DNA in CF expression 
systems, a PCR linear template, which contains the basic sequence region like T7-promotor and 
terminator, can also be used as efficient template. Recently, several researches were done to develop 
a practical method for preparing the linear PCR template for CF expression. A two-step PCR 
method developed by Yabuki, et. al, can provide robust, high-throughput production of linear 
template for CF protein synthesis. The procedure consist two step PCR: firstly, a target region 
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Figure 3. DNA template for CF expression. Essential T7 regulatory sequences are shaded and the corresponding 
sequences are indicated. Optional translated elements are dashed [58]. 
 
within the coding sequence is amplified using two gene-specific forward and reverse primers, which 
contain the linker sequences and the 5-prime sequences of the target region; secondly, PCR 
concatenates the first PCR product with the 5-prime and 3-prime double-stranded fragments, which 
contain the linker sequences as well as the sequences for the tag(s) and the initiation and termination, 
respectively, for T7 transcription and ribosomal translation, and amplifies it with the universal 
primer. Proteins can be fused with a variety of tags, such as natural poly-histidine, glutathione-S-
transferase, maltose-binding protein, or streptavidin-binding peptide [67].  
A strategy, so called ‘tag variation’, which focusing on the potential problems with 
translation initiation [68, 69], has been developed.  This fast tag variation strategy was designed by 
introducing non-functional tags of minimal size which located right at the 5-prime end of the target 
gene. This extra short sequence functions as translation enhancer. With combination of using linear 
PCR product, a fast and efficient protocol from the sequence design to the final protein expression 
yield determination was established.  This strategy can be classified into several sequential steps: (I) 
Preparing DNA templates by overlap PCR for each tag – target combination, (II) DNA template 
screening in analytical scale continuous exchange CF (CECF) reactions, (III) the potential further 
optimization of the most efficient DNA template and (IV) final CECF protocol optimization with 
the optimized DNA template for preparative scale production. With this strategy difficult MPs 
targets including GPCRs are used to exemplify the application. Results showed great improvement 
of expression yield was observed for most of the targets [70]. 
1.3.2.3 Compounds in CF system 
Besides the extracts, CF expression reactions consist of various essential compounds with 
defined and sometime critical concentration optima (Fig. 4). Divalent Mg
2+
 ions are essential for 
many biological reactions and the free Mg
2+
 concentration in CF extracts is a very hard to determine 
value. In order to obtain the maximum expression yield, it is therefore advisable to optimize Mg
2+
 
concentration for each new batch of prepared extract or even freshly prepared stock solution. With 
different CF systems the optimum concentration range of basic compounds like ions, can be quite 
different. For E. coli systems, the total Mg
2+
 ion concentrations typically range from 8-20 mM, 
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while eukaryotic translation systems include only 2-4 mM Mg
2+
 [71]. Potassium and ammonium 
acetate or the corresponding glutamates can be added into E. coli systems at high concentrations  
exceeding 200 mM. Wheat germ systems often contain 100 mM potassium acetate [71, 72]. ATP 
and GTP are sufficient to provide the required energy for mRNA translation in wheat germ systems, 
while four nucleoside triphosphates ATP/CTP/GTP/UTP are necessary in the coupled 
transcription/translation reaction type of E. coli CF expression systems. Amino acids are supplied in 
concentrations between 0.3 mM and 2 mM while even higher amounts of unstable amino acids (e.g. 
R, C, W, M, D, E) could significantly increase expression. MPs often have a strong bias in amino 
acid composition and adjusting the amino acid pool of the reaction accordingly could further 
increase the expression yields. Problems with the codon usage upon expression of heterologous 
genes could be addressed by modulating the total tRNA concentration or by addition of rare codon 
enriched tRNA. An alternative option would be to use synthetic genes designed according to the 
preferred codon usage of the chosen CF expression system.  
NTPs are essential energy sources, which are rapidly consumed in CF expression reactions. 
In addition, bacterial cell extracts have high endogenous ATPase and phosphatase activities which 
Figure 4. Schematic configuration of a coupled transcription/translation reaction in a CECF system. The CF 
reaction can be carried out in simple dialysis tubes placed into suitable plastic vials that hold the FM. The complete 
set-up is incubated e.g., on a turning device that ensures continuous agitation of the reaction and substance 
exchange between the two compartments. 
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will cause further uncoupled NTP hydrolysis. Sufficient energy supply is therefore the main 
bottleneck for CF protein synthesis and a number of modified protocols for E. coli systems have 
been developed as a major variation use different energy sources and pathways for the efficient 
energy regeneration. In conventional protocols, high-energy phosphate donors like phosphoenol 
pyruvate, acetyl phosphate or creatine phosphate are supplied as secondary energy substrate 
together with the corresponding kinases [73, 74]. However, the excess of phosphate generated as 
byproduct during the breakdown of energy sources and nucleotides is identified as an inhibitor of 
translation. In particular in batch configurations, the strategy of energy regeneration is of 
importance as accumulation of inhibitory phosphate should be minimized. However, those 
secondary energy substrate with high-energy phosphate bond are normaly quite expensive. 
Researches which designed to use other less expressive energy sources have been done to improve 
the application of this CF technique. Proposed modified energy regeneration pathways for batch 
systems use the oxidation of substrates from the glycolytic pathway (e.g. pyruvate, glucose-6-
phosphate, glucose) for the generation of ATP concomitant with the consumption of reaction by-
products [75]. The “PANOx” system combines phosphoenol pyruvate as the conventional energy 
source with the addition of nicotinamide adenine dinucleotide and coenzyme A in order to use in 
addition pyruvate for ATP regeneration [76]. Protocols using alternative nonphosphorylated energy 
sources like pyruvate in the “Cytomim” system have further been developed [77]. Oxidative 
phosphorylation, the most efficient natural source of ATP, is used and potassium and magnesium 
glutamate as well as the polycations spermidine and putrescine should also more closely mimic a 
cytoplasmic composition of the reaction. Having efficient energy regenerating systems, the 
relatively expensive NTPs could also be replaced by NMPs in order to generate a more cost-
effective system [75]. 
1.3.2.3 Configurations of CF system 
When the CF technique was first developed, the least complicated configuration was used. 
There was only one compartment contain all the necessary components of CF reaction. This kind of 
CF system configurations could allow continuous protein synthesis for a few hours or less 
depending on the speed of precursor consumption and the accumulation of inhibitory by-products. 
The final expression yield was relatively low. Research was done to improve and prolong the 
reaction time by introducing different metabolic path way of certain compounds. The results show 
that with optimization it was possible to obtain close to 1 mg of recombinant protein per 1 ml of 
reaction [78]. 
A remarkable strategy to optimize the efficiency of CF reactions was the design of 
continuous exchange CF (CECF) systems [79]. The principle is to separate the reaction into two 
compartments that are separated by a semipermeable membrane (Fig. 4). One compartment holds 
the reaction mixture (RM) with all high molecular weight compounds like the CF extract, enzymes 
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and nucleic acids. The second compartment provides a reservoir of low molecular weight precursors 
like NTPs, energy sources and amino acids and represents the feeding mixture (FM). The molecular 
weight cut-off of the separating membrane is usually relatively high and in between 10-50 kDa. It 
has to be emphasized that even at higher pore sizes no significant leakage of essential proteins from 
the translation machinery of the extract are leaking from the RM into the FM as they form a large 
complex through multiple interactions. Synthesized MPs also stay in the RM as the insertion into 
detergent micelles usually increases the molecular weight of even small proteins above 50 kDa. 
Efficient substance exchange between the two compartments through the membrane is ensured by 
vigorous stirring or shaking during incubation. The reaction time is significantly extended by the 
continuous supply of fresh precursors from the FM into the RM concomitant with the continuous 
dilution of inhibitory by-products from the RM into the FM. The ratio of the volumes of RM : FM is 
usually in between 1 : 10 and 1 : 50 and it is an important parameter for the final yield of 
recombinant protein. Higher FM volumes will certainly increase product yields, but not in a linear 
correlation. The exchange rate of compounds between the two compartments as well as the capacity 
of the CF extract will become more and more limiting and reduce the gain of yield. Considering the 
relatively high costs of the precursors in the FM, a ratio of approx. 1: 20 may be a reasonable 
compromise for maintaining CF expression for 6-8 hrs. with final yields of up to several mg 
recombinant protein per one ml of RM. 
Since CECF reactions have to be equipped with a membrane, their set up and handling is 
relatively complicated and limits their use in throughput applications. A bilayer system has recently 
been proposed as an interesting alternative configuration in particular for throughput purposes [80]. 
The bilayer system resembles a simplified version of the CECF system, in which the RM is 
carefully overlaid by the FM without separation by a membrane. Substances between the two layers 
exchange simply by diffusion and translation can be prolonged for several hrs yielding sub-
milligram amounts of protein which is sufficient for functional analysis. The reaction can be set up 
in micro-plates and a ratio of RM: FM of approx. 1: 5 is recommended for best performance. 
1.3.2.4 Expression mode of membrane proteins 
MPs can be synthesized in CF system in different ways. Without any additional 
hydrophobic reagent, the produced MP will result in the precipitant; with the addition of detergent 
in the CF reaction mixtures, the produced MPs will stay in soluble form. Recently, via adding lipids 
instead of detergent, MP can also be produced in their functional form or even soluble form. Both 
supplying with detergents and lipids are not possible with any other expression system, only with 
CF system as an open expression system that can create such artificial hydrophobic environment for 
MPs. Different expression modes are shown in Fig. 5. 
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Figure 5. Expression mode of CF production of MPs. In the precipitate mode (P-CF), no hydrophobic environments are 
provided, and the MPs precipitate after translation. In the detergent-based mode (D-CF), the synthesized MPs can stay 
soluble by insertion into the provided detergent micelles. In the lipid-based mode (L-CF), the synthesized MPs have the 
possibility to integrate into supplemented liposomes.  
1.3.2.4.1 P-CF mode 
In this standard and most simple CF expression mode, so called P-CF mode, MPs will be 
produced without any artificial hydrophobic environment. Therefore, all the MPs produced will 
result in the pellet form. This pellet is mainly the precipitated MPs, however, it is quite different 
from the precipitant when expressed in vivo. There are several differences: (I) Precipitates are 
always formed during the successful P-CF expression of MPs, while inclusion body formation is a 
much rarer event mostly observed with outer MPs. (II) P-CF generated precipitates can efficiently 
be solubilized with detergents by gentle shaking for few hours [81]. In contrast, inclusion bodies 
usually have to be solubilized with strong denaturants like high concentrations of urea or 
guanidinium hydrochloride. The subsequent refolding procedures require excessive dialysis steps 
and buffer exchanges in high dilutions. (III) The solubilization of P-CF generated MP precipitates 
can already result in functionally folded MPs as shown for example for the multidrug transporter 
EmrE [81, 82] or for the human histamine-1 receptor [83]. The successful refolding of MPs from 
inclusion bodies is so far mostly confined to outer MPs, whereas the functional refolding of α-
helical MPs remains the very exception. 
Precipitates obtained from P-CF reactions appear therefore to consist of less denatured or 
aggregated MPs if compared with inclusion bodies. This assumption is further supported by the 
recent observation of folded proteorhodopsin in P-CF generated precipitates. Structural features 
might therefore persist that could support the folding process of distinct MPs upon solubilization. 
Detergents that are highly efficient in the solubilization of P-CF generated precipitates and that still 
might allow a functional folding include DPC or the lyso-phosphoglycerols LMPG and LPPG. In 
addition, these detergents provide suitable environments for structural analysis of MPs by nuclear 
magnetic resonance spectroscopy (NMR). However, the functional solubilization of MPs from 
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precipitates is not a general process. Activities of P-CF produced and solublized samples of the 
nucleoside transporter Tsx and of the human endothelin-B receptor could not be observed [84, 85]. 
1.3.2.4.2 D-CF mode 
When the P-CF expressed MPs did not function, there is another way, which directly 
introduce reagents that can create a hydrophobic environment in the CF expression system. 
Therefore, the freshly produce MPs can get access to the hydrophobic environment, which can keep 
the MPs in a correctly folded soluble form. Detergents, one of the reagents which usually used as 
hydrophobic reagent, form micelles above certain concentration in solution. These micelles will 
provide the hydrophobic environment for MPs. The formation of MPs and detergents micelles 
complex, proteomicelles, is mainly based on non-specific hydrophobic interactions and do not 
require a translocation process, which in vivo will help the MPs insert into the membrane. Therefore, 
D-CF expression mode does not have the problems which originate from the transport and 
translocation process that often restrict the efficient production of MPs in the cell based 
conventional systems. 
Not all the detergents can be used in CF systems some with relatively high critical micellar 
concentration (CMC) like n-octyl-ß-D-glucopyranosid (β-OG) or 3-[(3- 
cholamidopropyl)dimethylammonio]-1-propansulfonat (CHAPS) start to inhibit the expression 
machinery of cell extracts already at concentrations hardly exceeding their CMCs, while the most of 
commonly used detergents are tolerated by CF systems in concentrations of at least several times 
CMC [84]. Especially, the relative mild detergents from the group of long chain polyoxyethylene-
ethers (Brij-derivatives) can be supplied into CF systems at final concentrations of more than 100 x 
CMC. Other detergents like Triton X-100 or DDM are also effective for the D-CF expression and 
solubilization of MPs, but the presence of higher concentrations starts to reduce the performance of 
the expression reaction. Further options of detergents include alkyl-glucosides like n-dodecyl-β-D-
maltoside (DDM) or steroid derivatives like digitonin. Digitonin and Brij-derivatives appear to be 
exceptionally efficient for the solubilization of a diverse variety of MPs in the D-CF expression 
mode. With both detergent groups, preparative scale amounts of solubilized samples of the 
multidrug transporter EmrE, the nucleoside transporter Tsx and the rat vasopressin-2 receptor could 
be produced in D-CF reactions [84]. Type and final concentration of the supplied detergent can have 
a strong impact on the quality and the yield of solubilized MP and these parameters should be 
subject of optimization in each D-CF expression approach [40, 84, 86]. The addition of detergent 
mixtures for the formation of mixed micelles could be a further interesting alternative. Lipids are 
discussed as important structural elements for the folding or stabilization of certain MPs [40] and 
providing detergent/lipid combinations in D-CF reactions could further be considered in order to 
optimize the quality of the produced MP. 
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Emphasize should be given to the extremely mild detergents, like the mentioned Brij-
derivatives, which could increasingly play a role in MP analysis. Those detergents are not able to 
disintegrate membranes and therefore have not been used so far for the solubilization of MPs by the 
conventional membrane extraction approach after MP production in cellular expression systems. 
However, their mildness is now a valuable property for their combination with CF synthesis as they 
are highly efficient in solubilizing MPs but do not interfere with protein synthesis. A similar effect 
might have fluorinated or hemifluorinated surfactants that are strongly hydrophobic but not 
lipophilic [87]. These amphipols probably do not compete effectively with protein-protein or 
protein-lipid interactions and could therefore stabilize the native fold of MPs under particularly mild 
conditions. The mechanosensitive channel MscL had similar electrophysiological activity after CF 
synthesis in presence of perfluorocarbons as after expression in vivo [87]. 
1.3.2.4.3 L-CF mode 
Lipids are the natural environment of MPs and in many cases essential for folding, stability 
and function. Defined lipid environment are often beneficial for functional and structural studies. In 
cells, it is known that MPs needs different mechanisms to be transported or targeted into the lipid 
bilayer. These processes require specific enzyme machineries, for instance, the Sec and SRP 
pathways for MP insertion [88, 89]. Although the in vitro reconstitution protocol was well 
established and most case efficient [81-83, 90], there are also some cases that lipids are necessary 
co-translational to obtain functional MPs. CF can provide such an system which lipids can be 
directly introduced. Recent reports have shown an effect of the charge of the employed lipids 
towards transcription and translation efficiency in the CF system. While transcription is usually not 
affected by the presence of any liposomes, translation may be inhibited by cationic lipids. Lipid 
concentration may furthermore influence the expression level [91, 92]. 
Lipids can be supplied into CF reactions in different formulations such as (i) preformed 
liposomes of defined compositions, (ii) isolated fractions of cell membranes, (iii) detergent 
solubilized lipomicelles providing a mixed environment for MPs, (iv) bicelles consisting of planar 
bilayers surrounded by detergents, and (v) nano-lipid particles or nanodiscs providing highly soluble 
and confined bilayer areas. Mechanisms of co-translational MP translocation could thus be analyzed 
in dependency of a large variety of lipid mixtures. Furthermore, MP integration into the provided 
bilayers may be more directed during L-CF mode expression, compared with the random orientation 
in classical posttranslational reconstitution approaches. In addition, the synthesized targets will be 
the only MP inserted into the bilayers and measured activities could thus clearly be attributed. These 
characteristics can have considerable benefits for subsequent functional studies. 
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Figure 6. L-CF modes for MP production. Lipids are provided in three basic forms, either as liposomes, lipid/detergent 
mixtures or nanodiscs. Illustrated is the recovery of the lipids together with the synthesized MPs after incubation in either 
supernatant or precipitated fraction of the reaction.   
 
A number of recent researches showed that functional MPs can be produced functionally. 
For example, bacteriorrhodopsin could be produced as membrane integrated protein after addition 
of artificial liposomes of defined composition in E. coli extracts [93]. A plant transporter and the 
membrane associated protein apo cytochrome b5 could be synthesized into preformed liposomes by 
using wheat germ systems [94, 95]. However, in all cases again only relatively low amounts of MP 
could be synthesized. In a very recent report, two E. coli transporters could be CF synthesized into 
purified E. coli inner membrane vesicles in amounts of several 100 μg per ml of RM [96]. A batch 
system was used and the activity of the L-CF produced tetracycline pump TetA was verified by a 
specific transport assay. The calculated surface coverage of the vesicles with up to 40% of 
recombinant protein was significantly higher if compared with data obtained from cellular 
expression systems. This work demonstrated that CF expression of MPs in the L-CF mode can even 
approach preparative scales and this technique might play a significant role in the next future for the 
functional analysis of MPs as well as for studying their specific translocation mechanism. 
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1.4 Cell-free in proteomic research 
With the completion of the genome sequences of many organisms, there is an increasing need for a 
high throughput expression of genome encoded proteins. However, the traditional in vivo cell based 
heterologous protein expression systems are not able to address this challenge because of the time 
consuming cloning procedures and later on sample preparations. However, CF technique, emerging 
as an alternative approach to cell-based methods, offers a simple, open and flexible system for fast 
synthesis of functional proteins. The time required from DNA sequence to the functional protein is 
dramatically shortened in CF expression system.  
1.4.1 Cell-free system for throughput application   
1.4.1.1 Large-scale analysis of proteins 
CF expression system has been widely used to determine the presence of a gene or open 
reading frame (ORF), especially when multiple samples or large genes are to be examined [97]. It 
can also be used to confirm an ORF predicted by DNA sequencing. In each case, the synthesized 
proteins are usually analyzed for size, biophysical properties and function [98]. CF protein synthesis 
has also been used as a routine screen for translation-terminating mutations in the diagnosis of 
genetic disease [99], a rapid method referred to as a protein truncation test (PTT). The truncated 
mutant alleles can be easily distinguished from the normal full-length protein product by sodium 
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). 
The successful rates in throughput expression screens are higher than in vivo expression 
systems, especially for difficult proteins like MPs. In addition, many critical and highly variable 
parameters like efficient gene delivery, template stability in cells, and suppression of background 
expression and induction of expression as well as considerations about optimal cell physiologies are 
eliminated. Furthermore, samples can be taken at any time point without disrupting the reaction. 
The possibility to use linear DNA fragments as template for CF expression is a further benefit for 
throughput applications. Products from appropriately designed PCR reactions including suitable 
promoter sequences could be used directly for expression analysis and time consuming sub-cloning 
procedures are not necessary [100, 101]. With the help of throughput CF expression system, not 
only screening large number of different targets at similar conditions is possible, but also large 
number of targets specific expression conditions screening is becoming feasible and efficient. The 
open nature of the CF system allowed target specific expression environment become possible. For 
instance, different chaperons and chemical compounds, which had effect on the protein folding, 
stability, can be added into the CF reaction system.  
Large number of expression screenings was performed with CF technique, including E. coli 
inner MPs, human proteins and so on [102, 103].  In the study of E. coli inner MPs, bioinformatics 
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analysis showed that about 1000 of the 4288 predicted genes encode integral inner MPs [38]. For a 
number of 737 prevalent α-helical topologies contain at least two trans-membrane segments (TMS). 
134 representative targets were selected and studied by CF expression system, covering the diverse 
MP families, protein sizes up to 1000 amino acids and up to 15 predicted TMSs. 112 targets, 
consisting of 84% of the total 134 targets, could be expressed either in P-CF or D-CF mode. This 
successful rate is particular high if compared with the cellular systems where usually the expression 
of not more than 30% of the targets is monitored [104-106]. Not only difficult prokaryotic proteins, 
but also eukaryotic proteins can be successfully expressed and studied in CF systems. Both E. coli 
CF system and wheat germ CF system were selected for large scale of eukaryotic proteome research 
[107, 108]. 
1.4.2 Cell-free system for generation of protein microarrays 
In the post-genomic era, high-throughput protein expression platforms are becoming 
increasingly important. Protein microarrays, which have gained popularity following the success of 
DNA microarrays, are miniaturized arrays containing small amounts of immobilized proteins. In 
microarrays [109], proteins are typically printed on glass slides, polyacrylamide gel pad slides, or 
microwells, each having its own advantages and drawbacks [110, 111]. This protein array approach 
allows studying hundreds or even thousands of proteins simultaneously in a single experiment [111]. 
There is great potential of protein microarrays in being flexible tools for large-scale analysis of 
functional proteins [112], such as antibody profiling [113], biomarker identification[114], protein-
protein interactions[115], and enzyme assays [116]. 
Traditional cellular approaches for the generation of protein microarrays involve expression 
of proteins in suitable heterologous system (e.g. E. coli, yeast, or mammalian cells), purification of 
expressed proteins, and immobilization of the purified proteins on to a solid support. With this cell-
based methods, laborious and time-consuming procedure that poses other technical challenges such 
as protein purity, maintenance of protein folding, and functionality during the purification and 
immobilization steps are often the bottleneck. 
CF expression system, as an alternative expression platform, has big advantage in 
developing a high-throughput protein express method. Using linear PCR template or circular 
plasmid for gene expression; short expression time and low reaction volume, all make the CF 
system an ideal tool for protein microarray. To circumvent the obstacles posed by traditional cell-
based methods, CF expression systems are now largely being adopted for the generation of protein 
microarrays. An optimized technology for this purpose must meet certain criteria: (i) It should be 
able to utilize a wide variety of DNA templates, in the form of PCR products or plasmids. (ii) The 
process should be simple, quick, and cost effective. (iii) Protein arrays should be produced on 
demand to avoid storage effects. (iv) It should allow for simultaneous production of thousands of 
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proteins in a single reaction. (v) Methods for the detection and analysis of the bound protein must be 
simple. 
1.4.2.1 Protein in situ array (PISA) 
PISA (protein in situ array, shown in Fig. 7) was the first well known cell free based in situ 
protein microarray technology that provided a rapid, single-step approach for the generation of a 
protein array from DNA fragments coupled with CF expression system followed by immobilization 
onto a solid support [117]. In this technique, the DNA constructs encoding the protein of interest 
contain a T7 promoter and sequences for translation initiation (Shine-Dalgarno or Kozak), an N- or 
C-terminal tag sequence for immobilization along with suitable termination sequences. The DNA 
constructs are produced by PCR amplification using a high fidelity TAQ polymerase. The surface is 
precoated with a tag capturing agent and the protein expression is carried out, commonly with E. 
coli S30 or rabbit reticulocyte lysates. After 
transcription/ translation, the expressed proteins bind 
specifically onto the surface through the tag sequence 
and the unbound material could be washed away. The 
authors of this technology made use of 6x histidine 
tag and a microtiter plate having 24 wells coated with 
nickel nitrilo-triacetic acid (Ni-NTA). They 
successfully achieved the expression and functional 
immobilization of a fragment of the human 
antiprogesterone antibody in microtiter wells and that 
of luciferase enzyme on Ni-NTA-coated magnetic 
beads. Quantification by Western blot analysis 
unveiled that 120 ng of protein was produced from the 
standard reaction volume of 25 µl, having 0.5-1 µg of 
PCR DNA, of which 50% was successfully 
immobilized in the microtiter wells [118].  
Figure 7. Methods for making protein arrays by in situ protein synthesis. (a) Protein in situ array (PISA) [118]. (b) 
Nucleic Acid Programmable Protein Array (NAPPA) [119]. (c) Puromycin capture [120]. ssDNA: single-stranded 
DNA[1]. 
 
PISA was the first technique and its success opened the door for other similar technologies 
in cell free based protein in situ arrays. However, the short comings of this technique included the 
need to utilize the PCR-generated DNA immediately after synthesis, relative high volume of CF 
lysate required, as well as a possible loss of protein function if the tag sequence interfered with the 
folding. 
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1.4.2.2 Nucleic acid programmable protein array (NAPPA) 
NAPPA was known as the first method to proof the possibility of direct conversion of DNA 
arrays into protein arrays by in situ CF protein synthesis. Unlike the method of PISA, in this method, 
DNA was first spotted onto a glass slide together with a protein-capturing reagent (an antibody in 
this case). The resultant DNA array was then covered with a CF transcription/ translation system on 
the array surface to express the proteins, which became trapped by the antibody colocalised in each 
spot. LaBaer and colleagues developed a method that used immobilized DNA templates, encoding 
the desired protein as a GST fusion, for in vitro transcription and translation (IVTT). In NAPPA, the 
biotinylated plasmid DNA was bound through avidin onto an aminopropyltriethoxysilane (APTES)-
coated slide, which also contained anti-GST antibodies bound to it for protein capture. Protein 
expression was then carried out by adding RRL to the arrays. The newly synthesized proteins, 
ranging in signal from 4 to 29 fmols, were captured by the antibody through the GST tag, and 
generated an array in which the protein was co-localized with its DNA[119]. 
This NAPPA method was further modified to generate high-density protein microarrays 
[121]. High yields of high quality DNA were obtained for immobilization by using a diamine-
derivatized resin. They also found that BSA improved the binding efficiency of DNA. A test array 
of cDNAs for 96 genes along with a negative control of non-expressing plasmid DNA and a 
concentration series of recombinant, purified DNA were printed. Around 97% of the printed 
samples were found to be detected by using the PicoGreen stain for ds-DNA, whereas anti-GST 
antibody detected protein signals for 99% of these 96 genes. This technique was effectively used to 
array up to 1000 unique human cDNAs, with an average protein yield of 9 fmol per feature. 
1.4.2.3 DNA array to protein array (DAPA) 
This innovative technique, developed by He et al., makes it possible to repeatedly use the 
same DNA template slide for printing multiple protein arrays. Different from NAPPA, the DAPA 
procedure produces pure protein arrays on a separated surface as shown in Fig.8. The idea of DAPA 
is that by carrying out CF protein synthesis within a membrane filter sandwiched between two glass 
slides, on one of which is an array of immobilized PCR DNA molecules while the other is coated 
with a reagent to capture translated proteins [1]. Individual proteins are produced in parallel within 
the membrane. Then the synthesized proteins diffuse through the membrane filter and are 
immobilized on the opposite surface via interaction with the protein-capturing reagent, which form a 
protein array with the same pattern as the DNA array [1].  
Data showed that more than 20 copies of a protein array can be produced by use of a single 
DNA template, repeatedly [122], which made it useful for repeated printing of protein arrays in 
laboratories without access to microarray spotters. But, there is also some limitation for this 
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technique. That is the protein diffusion during membrane penetration, especially with regard to 
larger multi-meric proteins. 
 
1.4.2.4 Arraying of nascent 
proteins by in situ puromycin 
capture 
New research was done to 
make an adjustment of mRNA 
display [123]. This adaption using 
in situ puromycin capture of 
nascent polypeptides to facilitate 
protein arrays [120]. This 
approach requires additional 
manipulation procedures to make 
mRNA–ssDNA hybrid molecules before printing and protein yields are limited by the amount of 
mRNA spotted. Similar method, exemplified by solid phase immobilisation on beads, has also been 
reported [1, 124]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Principle of DAPA technology[1]. 
 
Materials 
 
-36- 
 
2. Materials 
2.1 Laboratory equipment 
0.22-μm polysulfone filters (Roth) 
10-liter fermenter (B.Braun) 
96F Nunclon Delta Black Microwell SI (Nunc, ON 137101) 
Äkta purifier (GE Healthcare Amersham) 
Autoclave (Getinge) 
Balance (Sartorius) 
Centrifuge 
Centriprep devices YM-10 (Amicon) 
Cooled table top centrifuge 
Dialysis tubes type 27/32 MWCO 14 kDa (Spectrum, Rancho Dominguez) 
DispoDialyser 25 kDa MWCO, regenerated cellulose (Spectrum, Rancho Dominguez) 
French press / Cell disrupter 
Gel imager (Biometra) 
Glass vials (e.g., Rotilabo vials; Roth) 
Heating block (VWR) 
ITHACO electrometer (ITHACO, NY, USA) 
Lumi Imager P1 (Roche Diagnostics) 
MicroDispoDialyser 25 kDa MWCO, regenerated cellulose (e.g., Roth) 
Microwave (Alaska) 
Midi DNA preparation kit (e.g., Qiagen) 
Mini-extruder (Avanti lipids) 
Nanodrop 100 (peqlab) 
Ni-NTA Superflow resin (Qiagen) 
pH-meter PHM 210 (Radiometer) 
Pipettes (Abimed, Gilson) 
Plate Centrifuge Rotana 46RSC-Robotic (Hettich) 
PS-microplate 96well V-shape ON 651101 (Greiner bio-one) 
QIAquick gel extraction kit (Qiagen) 
QIAquick PCR purification kit (Qiagen) 
Rolling device (e.g., Fröbel Labortechnik) 
SDS-polyacrylamide gel electrophoresis system 
SEC columns: Superdex200 3.2/30 
Shaker (Heidolph) 
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Shaking incubator (New Brunswick) 
Slide-A-lyzer dialysis cassette 10 kDa MWCO (Pierce) 
Sonifier Labsonic U (B.Braun) 
TECAN cooled carrier 
TECAN FreedomEVO 200/8 
TECAN GENiosPro plate reader 
TECAN shaked plate incubator / Thermoshaker 
TECAN Te-mags 
Temperature-controlled shaking incubator 
Thermocycler (Bio-Rad, Eppendorf) 
UV/Vis spectrometer (Cary) 
Vacuum pump (Abm) 
Vortexer Reax 2000 (Heidolph) 
Waterbath 
Western blotting system (BioRad) 
2.2 Reagents 
1,4-Dihydrobutane dihydrochloride (Putrescine) (Sigma) 
1,4-Dithiothreitol (Roth) 
2-Mercaptoethanol (Sigma Aldrich) 
2x yeast tryptophan peptone glucose (YTPG) medium (see Buffers) 
Acetyl phosphate lithium potassium salt (Sigma Aldrich) 
Adenosine 5-triphosphate disodium salt trihydrate (Roche Diagnostics) 
Amino acids (Sigma Aldrich) 
Antibodies: anti-biotin peroxidase conjugate (Sigma); anti-gree fluorescent protein from rabbit 
(Calbiochem); anti-mouse IgG HRP conjugate from goat (Sigma Aldrich); anti-penta His IgG from 
mouse (Qiagen); goat anti-rabbit IgG (Calbiochem); T7 tag antibody HRP conjugate (Novagen) 
Antifoam Y-30 emulsion (Sigma Aldrich) 
Bactotryptone (Roth) 
Benchmark protein ladder (Invitrogen) 
Coenzyme A sodium salt hydrate (Sigma) 
Complete protease inhibitor mix (Roche Diagnostics) 
Cytidine 5`triphosphate disodium salt hydrate (Fluka Sigma Aldrich) 
Detergents (Sigma Aldrich, Anatrace, Avanti Polar Lipids, Glycon): Brij-35, polyoxyethylene-(23)-
lauryl-ether; Brij-56, polyoxyethylene-(10)-cetyl-ether; Brij-58, polyoxyethylene-(20)-cetyl-ether; 
Brij-72, polyoxyethylene-(2)-stearylether; Brij-78, polyoxyethylene-(20)-stearyl-ether; Brij-97, 
Materials 
 
-38- 
 
polyoxyethylene-(10)-oleyl-ether; Brij-98, polyoxyethylene-(20)-oleyl-ether; C10E5, Pentaethylene 
Glycol Monodecyl Ether; C8E5, Pentaethylene Glycol Monooctyl Ether; C12E8, Octaethylene 
glycol monododecyl ether; β-OG, n-octyl-β-glucopyranoside; FG, n-Heptyl-β-D-Glucopyranoside; 
NG, n-Nonyl-β-D-Glucopyranoside; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-
propansulfonat; DHPC, 1,2-diheptanoyl-sn-glycero-3-phosphocholine; diC6PC, 1,2-dihexanoyl-sn-
glycero-3-phosphocholine; diC8PC, 1,2-dioctanoyl-sn-glycero-3-phosphocholine; DM, n-decyl-β-
maltoside; DDM, n-dodecyl-β-D-maltoside; NM, n-Nonyl-β-maltoside; DMPC, 1,2-dimyristoyl-sn-
glycero-3-phosphocholine; DPC, dodecyl-phosphocholine; LMPG, 1-myristoyl-2-hydroxy-
snglycero-3-[phospho-rac-(1-glycerol)]; LPPG, 1-palmitoyl-2-hydroxy-sn-glycero-3-[phospho-rac-
(1-glycerol)]; Lauryl-MNG, 2,2-didecylpropane-1,3-bis-β-D-maltopyranoside; Decyl- MNG, 2,2-
dioctylpropane-1,3-bis-b-D-maltopyranoside; C6F-TAC, C6F13C2H4-S-
poly[tris(hydroxymethyl)aminomethane; C8F-TAC, C8F17C2H4-S-poly[tris(hydroxymethyl); SDS, 
sodium dodecylsulfate; Triton X-100,; Tween 20, polyoxy-ethylene sorbitan monolaurate 20; 
Tyloxapol. 
E. coli A19 (E. coli Genetic Stock Center) 
Ethidiumbromide (Roth) 
Folinic acid calcium salt (Sigma Aldrich) 
Gene ruler 1kb DNA ladder (Fermentas) 
Glucose monohydrate (Roth) 
Guanosine 5`triphosphate disodium salt hydrate (Fluka Sigma Aldrich) 
Hemin (Sigma) 
HEPES (Roth) Imidazole (Roth) 
2.3 Bacterial strains 
Table 1. Bacterial strains 
Strain Genotype Reference 
E. coli DH5α [F-,endA1, hsdR17 (rk-mk-), supE44, thi-1, recA1, 
gyrA (Nalr), relA1, Δ(lacZYA-argF)U169, 
Φ80lacZΔM15] 
[125] 
E. coli BL21(DE3) hsdS, gal [λcI, ts857, cnd1, hsdR17, recA1, endA1, 
gyrA96, thi-1, relA1] 
[126] 
E. coli K-12 A19 [rna19 gdh A2 his95 relA1 spoT1 metB1] E. coli Genetic 
stock center, New 
Heaven, CT 
2.4 Software 
Gemini 4.2.17.304 
Tecan Magellan 5.03 
UNICORN 5.11 
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E.Y.E.S 1.0 
2.5 Common buffers/media/reagents 
Buffers and Media for S30 extract and T7 polymerase preparation: 
40 x S30-A/B buffer: 400 mM Tris-acetate, pH 8.2, 560 mM Mg(OAc)2, 2.4 M KCl.   
 Supplement 1 x S30-A buffer with 6 mM ß-mercaptoethanol.  
 Supplement 1 x S30-B buffer with 1 mM DTT and 1 mM PMSF. 
40 x S30-C buffer: 400 mM Tris-acetate, pH 8.2, 560 mM Mg(OAc)2, 2.4 M KOAc. 
 Supplement 1 x S30-C buffer with 0.5 mM DTT. 
2x YTPG medium: 22 mM KH2PO4, 40 mM K2HPO4, 100 mM glucose, tryptone 16 g/l, yeast 
extract 10 g/l, NaCl 5 g/l.  
LB medium: Peptone 10 g/l, yeast extract 5 g/l, NaCl 5 g/l. 
Buffer T7RNAP-A: 30 mM Tris-HCl, pH 8.0, 50 mM NaCl, 10 mM EDTA, 10mM ß-
mercaptoethanol, 5% glycerol. 
Buffer T7RNAP-B: 30 mM Tris-HCl, pH 8.0, 50 mM NaCl, 1 mM EDTA, 10 mM ß-
mercaptoethanol, 5% glycerol. 
Buffer T7RNAP-C: 30 mM Tris-HCl, pH 8.0, 1 M NaCl, 1 mM EDTA, 10 mM β-mercaptoethanol, 
5% glycerol. 
Buffer T7RNAP-D: 10 mM K2HPO4/KH2PO4, pH 8.0, 10 mM NaCl, 0.5 mM  EDTA, 1 mM 
DTT, 5% glycerol. 
20% streptomycin sulphate. 
Reagents for CF reaction: 
50 x Complete® protease inhibitor cocktail (Roche Diagnostics) 1 tablet per 1 ml of MilliQ water. 
Amino acid mixtures containing 4 mM or 8 mM of each of the 20 natural amino  acids. 
RCWMDE mixture containing 16.7 mM of each amino acid. 
1 M acetyl phosphate lithium potassium salt (AcP) (Sigma-Aldrich), adjusted to  pH 7.0 with KOH. 
1 M phospho(enol)pyruvic acid K
+
 salt (PEP) (Sigma-Aldrich), adjusted to pH 7.0 with KOH. 
NTP mixture containing 90 mM ATP, 60 mM CTP, 60 mM GTP and 60 mM UTP, adjusted to pH 
7.0 with NaOH. 
Pyruvat kinase (Roche Diagnostics), 10 mg/ml. 
RiboLock® RNAse inhibitor (Fermentas), 40 U/µl. 
Total E. coli tRNA (Roche Diagnostics), 40 mg/ml. 
Folinic acid, Ca
2+
 salt, 10 mg/ml (Sigma-Aldrich). 
Polyethylene glycol 8000 (PEG 8000), 40% (w/v). 
4 M potassium acetate (KOAc). 
2.4 M Hepes/ 20 mM EDTA, pH 8.0 adjusted with KOH. 
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500 mM 1,4-dithiothreitol (DTT). 
E. coli S30 extract, store frozen at -80
o
C  
T7-RNA polymerase (T7RNAP), store frozen at -80
o
C  
Template DNA (plasmid DNA or linear PCR products) 200-500 ng/μl 
Reaction container: Analytical and preparative scale reaction container; D-tube containers, 12-14 
kDa MWCO (Merck Biosciences); Slide-A-Lyzer, 10 kDa MWCO (Pierce); dialysis tubes, 14 kDa 
MWCO. 
10 x Premix: 15 mM putrescine, 15 mM spermidine, 2.5 M K
+
-glutamate, 100 mM NH4+-glutamate, 
100 mM Mg
2+-
glutamate, 40 mM Na
+
-oxalate, 330 mM Na
+
-pyruvate, 340 µg/ml folinic acid, 10 
mM DTT, 5.3 mM NAD
+
. 
30 mM CoA-Na
+
. 
GFP assay buffer: 20 mM Tris, 150 mM NaCl, pH 7.8. 
1000×Ampicillin stock: Dissolve 100 mg/ml Na
+
-Ampicillin salt in 50% H2O and 50% EtOH. Store 
at -20°C. 
1000×Kanamycin stock: Dissolve 30 mg/ml kanamycin sulfate in H2O. Store at -20°C. 
SDS-gel buffers:  
Stacking gel buffer: 0.4% (w/v) SDS, 0.5 M Tris-HCl, pH 6.8.  
Separating gel buffer: 0.4% (w/v) SDS, 1.5 M Tris-HCl, pH 8.9.  
5×SDS-PAGE sample buffer: 25% (w/v) glycerol, 25% (v/v) β-mercaptoethanol, 7.5% (v/v) SDS, 
0.05% (w/v) bromphenol blue, 300 M Tris-HCl, pH 6.8.  
Running buffer: 0.025 M Tris-HCl, pH 8, 0.1% (w/v) SDS and 0.2 M glycine. 
Tricine-SDS- PAGE buffers: 
10×Anode buffer: 1.0 M Tris-HCl, pH 8.9 
10×Cathode buffer: 1.0 M Tris, 1.0 M Tricine, 1.0% (w/v) SDS, pH ~8.25 
3×Gel buffer: 3.0 M Tris-HCl, 0.3% (w/v) SDS, pH 8.45 
Coomassie brilliant blue-staining solution for SDS gels:  
50% (v/v) ethanol (96%), 10% (v/v) acetic acid (100%) and 0.1% (w/v) Coomassie Brilliant Blue 
G250 + R250. Dissolve in H2O and store at RT in a dark bottle. 
Western-blotting buffer (Towbin): Dissolve 25 mM Tris, 192 mM Glycin, 3.5 mM (1%) SDS, 15% 
MeOH in H2O and adjust to pH 8.3 by HCl. Store at 4°C. 
ECL1: 100mM Tris (pH 8.5), 2.5 mM Luminol, 0.4 mM p-cumaric acid. Store at 4°C. 
ECL2: 100mM Tris (pH 8.5), 0.0183% H2O2. Store at 4°C 
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3. Methods 
3.1 DNA template 
sGFP (shifted green fluorescence protein, red mutant) was cloned into the pIVEX 2.3d 
(Roche Diagnostics, Penzberg, Germany) vector with C-terminal poly(His)10 tag. 
The 552 bp GNA1 cloned from plasmid pRGNA1 (conserved by Wang’s lab in South 
China University of Technology), contains BamHI or XhoI restriction site indicated by underlines. 
756 bp sGFP which consists of an intermediate TEV cleavage site obtained from plasmid sGFP (red 
mutant) respectively. Used primers are described in Tab. 2. The PCR cloning products were inserted 
into a modified vector pET21a (Merck Biosciences, Darmstadt, Germany) carrying T7 promoter and 
a poly(His)10-tag using RF cloning as described by [127]. The sequences of the primers used for 
cloning are given in Tab. 2 
 
Table 2. construct for GNA1 and GNA1-sGFP and sGFP 
Construct Vector Type Sequence(5’- 3’) 
GNA1 pET21a BamHI CGCGGATCCATGAAACCTGATGAAACT
CCT 
  XhoI CCGCTCGAGCTTTAGAAACCTCCGACA
CA 
GNA1-sGFP pET21a RF CTACATGTGTCGGAGGTTTCTAAAGGG
CGAAAACCTGTACTTCCAGGGCG 
  RF GGTGGTGGTGGTGGTGGTGCTCGAGTG
CGGCCGCAAGCTTTTTGTAGAGC 
 
The CurA-halogenase is a dimeric protein which was crystalized in 2010 [128]. We 
received the construct as a gift from D. Sherman. CurA-halogenase was cloned into the vector 
pET28b with an N-terminal His6-tag. The native protein sequence covers the amino acids 1599 to 
1930 of CurA according to the sequence accessible at NCBI (GenBank accession code: 
AAT70096.1) 
DNA templates used for CF expression were transformed into DH5α competent cells and 
isolated by plasmid purification kit (Macherey-Nagel, Germany). 
The 903 bp mAQP4 M23 gene was amplified from the plasmid T-vector-AQP4 M23 
(obtained from Dongbei Normal University, China). The following two primers were used: 5’-
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GGAATTCCATATGGTGGCTTTCAAAGG-3’ and 5’-GCCCGCTCGAG TACGGAAGACAAT-
3’. The NdeI and XhoI restriction sites used for cloning are shown underlined. The restricted PCR 
products were ligated into a modified vector pIVEX 2.3d (Roche Diagnostics, Penzberg, Germany) 
containing a poly-(His)10-tag. DNA templates used for CF expression were isolated from the 
resulting plasmid pIVEX2.3d-AQP4 M23 using commercial kits (Qiagen, Hilden, Germany).  
3.2 Cell-free expression 
3.2.1 Continuous exchange cell-free configuration 
The preparation of T7-RNA polymerase, S30 extract and the final set-up of analytical as 
well as preparative scale reactions were performed as described in detail [57]. 
3.2.2 Batch configuration 
As reaction container, standard 96-well v-shaped micro-plates or reaction tubes can be used. 
Total volumes of ≥ 25 µl are recommended for batch screening reactions in 96-well micro-plates.  
The standard reaction mixture (RM) contained the following components: 2.5 mM ATP, 1.7 
mM each of GTP, UTP and CTP, 34 mg/mL folinic acid, 170 mg/mL E. coli tRNA mixture (Roche, 
Indianapolis, IN, USA), 4-15 ng/µL of plasmid vector, 10 µg/mL T7 RNA polymerase, 2mM each 
of 20 unlabeled amino acids, 0.53 mM NAD, 0.26 mM CoA, 280 mM potassium glutamate, 10mM 
ammonium glutamate, 10 mM magnesium glutamate, 1.5 mM spermidine, 1.5 mM putrescine, 4mM 
sodium oxalate, 2 mM DTT and 0.24 volume of S30 extract [57]. 
TECAN Freedom EVO 200/8 equipped with one liquid handling and two transport arms 
was used to perform the pipetting the batch reactions. In order to perform fast and reliable pipetting, 
4 needles each combined with a 1000μL syringe and 4 needles each combined with a 50 μL syringe 
were combined with liquid handling. All substances and destination vessels (e.g. 2 mL reaction-
tubes) are kept during pipetting at 4°C on a water bath cooled carrier (e.g. Cooling carrier for 2x16 
reaction tubes; Cooling carrier for 3x96/394well plates in half-height or deep-well format). As the 
penultimate component the NTP-mix is added (before diluent), which functions as a kind of 
'reaction starter'. Finally the plate was manually sealed with Parafilm and incubated at 32°C and 
9Hz shaking speed on a TECAN shaking incubator for 3h. 
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3.3 Electrophoresis 
3.3.1 SDS-PAGE and western blotting 
For SDS-gel analysis, protein samples supplemented with SDS sample buffer were loaded 
on 12% or 16.5% (w/v) Tris/glycine/SDS or Tricine/SDS gels and stained with Coomassie blue 
(shown in Tab. 3, Tab. 4). Protein sample was mixed with the 5 x SDS-PAGE Sample buffer and 
incubated at 98 
o
C for soluble protein, 37 
o
C for MP for 10 min. Then the sample was spin down at 
18000g for 30 seconds. The supernatant was loading onto the gel. The running of the gel started 
with 100 V for 15 min and followed by 200 V for 45 min with constant current (time might change 
with different percentage of separating gels). 
 
Table 3. Pipetting scheme for SDS-PAGE gels 
Compounds Separating 
gel 
12% 
Separating 
gel 
16% 
compounds Staking gel 
4% 
1.5 M Tris/HCl pH 
8.8 
2.5 ml 2.5 ml 0.5 M Tris/HCl pH 
6.8 
2.5 ml 
30% Acrylamide 4 ml 5.3 ml 30% Acrylamide 1.3 ml 
10% SDS 0.1 ml 0.1 ml 10% SDS 0.1 ml 
10% APS 50 µl 50 µl 10% APS 25 µl 
TEMED 5 µl 5 µl TEMED 5 
H2O 3.4 ml 2.1 ml H2O 6.1 
Total ~10 ml ~10 ml Total ~10 ml 
 
Table 4. Pipetting scheme for Tricine-SDS-PAGE 
Compounds Separating gel (10%) Separating gel (12%) Stacking gel (4%) 
30% (w/v) 
Polyacrylamid (37.5:1) 
10 ml 12 ml 1.65 ml 
Gel buffers 3× 10 ml 10 ml 3 ml 
Glycerol 3 ml 3 ml 0 
APS (10%) 150 µl 100 µl 30 µl 
TEMED 15 µl 10 µl 3 µl 
H2O 6.83 ml 4.9 ml 7.32 ml 
Total ~30 ml ~ 30 ml ~ 12 ml 
 
For western blot analysis, the gels were transferred on a 0.45 μm Immobilon-P 
poly(vinylidene difluoride) membrane (Millipore) in a BioRad wet western blot apparatus for 50min 
at 350 mA. For Dot blot analysis samples were directly applied on a nitrocellulose membrane 
(Sartorius, Göttingen, Germany) and stored at 37°C until the sample was totally dry. Membranes 
were blocked for 1 h in blocking-buffer containing 1 x Tris buffered saline, 4% skim milk powder 
(Fluka) and 0.05% (w/v) Tween20. 
Horseradish peroxidase-conjugated T7-tag antibody (Merck Biosciences) was used for 
detection at a dilution of 1:5.000 and incubated for 1 h with the membrane. His-tag was detected by 
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anti-penta His IgG from mouse (Qiagen) in a 1:2.000 dilution, the membrane was washed 3times 
with 1 x Tris buffered saline and 0.05% Tween20. As a second antibody an anti-mouse IgG HRP 
conjugate from goat (Sigma Aldrich) was used in a 1:5.000 dilution.  
3.4 Protein purification 
3.4.1 mAQP4 M23 purification 
The CF expressed mAQP4 M23 was purified in one step by imobilized metal-chelated 
affinity chromatography (IMAC). 1 ml of either D-CF soluble expressed mAQP4 M23 or P-CF 
resolubilized mAQP4 M23 was mixed with 300 µl of Co
2+
 loaded NTA resin slurry (Qiagen, Hilden, 
Germany). The mixture was diluted 10-fold with column buffer (20 mM Tris-HCl, pH 7.8, 300 mM 
NaCl, 20 mM imidazole, 0.05% DDM or 0.05% Fos-12) and incubated at 4oC for overnight with 
gently shaking. The mixture was poured into an empty column and washed at gravity flow rate of 
ten column volumes of column buffer supplemented with 80 mM imidazole. The bound mAQP4 
M23 was then eluted with column buffer supplemented with 300 mM imidazole. 
3.4.2 Size exclusion chromatography 
SEC with prepack columns (GE Healthcare, Munich, Germay) Superdex 200 PC 10/300 or 
Superdex 200 PC3.2/300.  
 
3.5 Protein quantification 
3.5.1 Fluorescence 
After expression, keep GFP/sGFP samples at 4
o
C for 12 hours to allow complete  GFP 
folding. Add 3 µl of sample into 297 μl GFP assay buffer in a 96-well dark micro-plate. Incubate the 
plate with shaking for 5 min at 22
o
C. Fluorescence measurement for sGFP is performed at an 
excitation wavelength of 484 nm and an emission wavelength of 510 nm. For wild type GFP the 
excitation wavelength is 395 nm with an emission wavelength of 510 nm. Use a calibration curve 
with purified GFP/sGFP to quantify the measured fluorescence. 
3.5.2 Western blotting 
Positope™ was used as standard protein positive control for western blotting quantification. The 
procedure for western blotting was performed as above in 3.3.1 
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3.5.3 
35
S-Met Incorporation 
S35 labeled methionine was used for radioactive quantification. S35 labeled methionine was 
mixed with non-label amino acids mix with a ratio of 1: 40,000 and then the mixture were added 
into the reaction mixture for expression. After incubation, the reaction mix was collected and 
transferred into eppendorf tubes. Then the total protein was quantified by a TCA precipitation. Add 
ice-cold TCA (15%, w/v) into the sample to reach final concentration of 10%, centrifuge at 
22,000xg for 10 min at 4 
o
C. The pellet was washed two times by 10% ice-cold TCA and one time 
of 95% ethanol. Carefully remove the supernatant and dry the pellet then the eppendorf tube 
containing the dried pellet was dropped into a scintillation vial, 20 ml (Carl Roth, Karlsruhe, 
Germany) filled with 5 ml scintillation cocktail Rotiszint®eco (Carl Roth, Karlsruhe, Germany). 
Turn the vial upside down to allow efficient contact between the scintillation liquid and the pellet. 
After 1-2 hours, the scintillation is counted for 1 min using a liquid scintillation counter (LS6500, 
Beckmann).    
3.6 Functional analysis 
3.6.1 Liposome preparation 
E. coli polar lipids or other artificial lipids were purchased from Avanti Polar Lipids, Inc. 
(Alabaster, AL). Lipid mixtures solubilized in chloroform were first transferred to a round bottom 
flask. A thin lipid film was formed by evaporating the chloroform under a nitrogen stream and 
placing the flask in a vacuum chamber for overnight. The lipids were then reconstituted in 1 ml of 
assay buffer (100 mM MOPS-KOH, pH 7.5) or S30 C buffer to a final concentration of 20 mg/ml 
by vortexing for 15 min to form multilamellar vesicles. The multilamellar vesicle solution was 
passed at least 21 times through an Avanti Polar Lipids mini extruder holding a 200 nm Whatman 
polycarbonate membrane filter (Florham Park, NJ) sandwiched with two filter supports on each side. 
The resulting unilamellar liposome solution was used for MP reconstitution. 
3.6.2 Reconstitution  
IMAC purified mAQP4 M23 protein was reconstituted into liposomes composed of E. coli 
polar lipids (Avanti Polar Lipids, Alabaster, AL, U.S.A.) by modification of a previously published 
protocol [129]. Briefly, a reconstitution mixture was prepared in a microtube at room temperature 
by sequentially adding reconstitution buffer (100 mM Mops, pH 7.5), 10% (v/w) Triton X-100 
Methods 
 
-46- 
 
(final concentration 4 mM), 20 mg/ml preformed liposomes (final concentration 4 mg/ml), and 100 
µg/ml purified mAQP4 M23. The reconstitution mixture was incubated at room temperature with 
gently shaking for 30 min. The detergent was removed by SM-2 beads (Bio-Rad, München, 
Germany) according to the manual. Finally, the liquid reconstitution mixture was sent to 
ultracentrifugation at 500,000 g for 45 min. Then, the pellet was washed again with reconstitution 
buffer. After wash step, the proteoliposome solution was ultracentrifugated again and finally 
resuspended in 1.6 ml reconstitution buffer. 
3.6.3 Water channel activity assay 
Water permeability was measured by 90 degree light scattering at 436 nm in a stopped-flow 
spectrophotometer (SFM 300, BioLogic). Before measurement, the proteoliposomes were extruded 
once through a 200 nm membrane filter for homogenization. Proteoliposomes suspended in 
reconstitution buffer were quickly mixed with equal volumes of a hyper-osmotic solution 
(reconstitution buffer with 400 mM sucrose). Because sucrose does not penetrate into the 
proteoliposomes, the applied osmotic gradient initiates a water efflux. The resulting shrinking of the 
liposomes can be recorded by light scattering analysis. Data were fitted to an exponential rise 
equation, and the initial shrinkage rate (k) was determined by the average of at least three fitted 
equations. The water permeability factor Pf of the proteoliposome samples was calculated as 
described previously [130] using the equation: 
0
f
( / ) w osm
k
P
S V V

 
 
where S/V0 is the vesicle’s initial surface to volume ratio, Vw the partial molar volume of 
water (18 cm
3
 mol
-1
), and osm the osmotic driving force. The S/V0 was calculated by determining 
the diameter of the proteoliposomes using dynamic light scattering (ZetaPlus particle sizing 
software 2.27). The diameter of the proteoliposomes and empty liposomes were determined to be 
113 nm. The osm  was 200 mM in this case. 
Here one specific example was given as follows:  
We take the D-CF reconstituted proteoliposome at 10
o
C as an example. k were obtained by 
three curve fitting to be 24.42, 25.33, 26.57. Then S/V0 was 5.31×10
7
 m
-1
. So the final Pf were 
127.75 µm/s, 133.0 µm/s, 139 µm/s, respectively. Then the mean value and SD was given as 133.1 
± 5.6 µm/s 
3.6.4 Activity Assay of the Cell-free synthesized GNA1-sGFP 
After expression, reaction mixture were collected and transferred into D-tubes. In order to 
get a better exchange of the dialysis, reaction mixture was diluted into 100 μl with buffer (50 mM 
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Tris-HCl, pH 8.0, 5.0). Then the samples were dialysis against 500 ml buffer with stirring at 4 
o
C for 
2 hours. Then the sample was collected and centrifuge at 22,000xg for 10 min. Supernatant was then 
used for enzyme activity assay. Activity was measured as previously described [2] with 
modifications. The assay was performed in 50 µl of mixture buffer containing 500mM GlcN6P, 
500mM AcCoA, 50 mM Tris-HCl, pH 8.0, 5.0 mM MgCl2 and 10% glycerol in 96-well flat bottom 
plates, and approximately 0.2 μg of purified CECF expressed GNA1 and 0.4 µg unpurified GNA1-
sGFP were added to start the reaction, respectively. After incubation at 30 
o
C for 5 mins, the 
reaction was terminated by adding 50 μl of the stop solution (50 mM Tris–HCl, pH 8.0, and 6.4M 
guanidine hydrochloride) and then 50 μl of CR buffer (50 mM Tris–HCl, pH 8.0, 1 mM EDTA, and 
200 uM DTNB). The amount of CoA produced by the GNA1 was estimated by 4-nitrothiophenolate 
and measured at the optimal density of 412 nm on full wave length spectrophotometer microplate 
reader (Thermo Scientific, USA). A blank reaction using CF reaction mixture without GNA1 or 
sGPF protein was set up as background control. The amount of CoA produced was calculated using 
the extinction coefficient of DTNB at 30 
o
C (13,800 M
-1
 cm
-1
). 
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4. Results  
4.1 Establishing high-throughput cell-free expression platform  
The open nature and the high success rate of CF systems enable throughput expression 
condition screening as a new rational strategy for protein expression. Quality and production of 
proteins can be optimized by extensive modification of their direct expression environment. 
However, even with CF system, to find suitable stabilizers or folding enhancers still require large 
amount of screening experiments for each specific protein target. In order to find a solution to this 
time consuming procedure, we introduce a robotic pipetting system, based on Tecan Freedom EVO 
200 workstation, to perform all the pipetting work for compounds screening via CF expression 
system[57]. Studies were already done to introduce the robotic pipetting system to perform the CF 
expression. Aoki et al introduced robotic system to pipetting the CF reactions using the continuous 
exchange mode, which suitable for preparative scale sample production [131]. However, we still 
chose the batch mode because of its easy handling and high-throughput. For screening purpose, the 
expression level of batch mode was already sufficient for detection[132]. With the help of custom-
designed operation software E.Y.E.S program, time required for programing and pipetting was 
greatly reduced, around 30-45 min per 96 reactions. The use of robotic liquid handling systems and 
calculation programs will largely facilitate such throughput applications.  
4.1.1 Setting up batch cell-free system via robotic pipetting  
With the goal of setting up an automated CF expression platform, we introduced the robotic 
pipetting platform of TECAN Freedom EVO 200, which contains one liquid handling and two 
transport arm as shown in Fig. 9. In considering to minimizing the CF reaction volume, and 
covering the most frequent used pipetting volume, we select a set of tips and syringes (4 tips each 
combined with 1000 µl syringe; 4 tips each combined with 50 µl syringe) for the robot to allow us 
perform accurate and fast liquid pipetting work ranging from nanoscale volume to milliscale. 
Cooling carriers for 50 ml falcon tubes; 15 ml falcon tubes; 2×16, 1.5-2 ml eppendorf tubes; 3 
position for 96/394 well plates are introduced to keep all the temperature sensitive compounds and 
CF reactions. Thermo-shaking devices are also introduced for CF reaction incubation and shaking. 
4.1.1.1 Establishing an efficient batch CF expression protocol 
The simple batch format CF expression protocols are becoming more and more productive 
and the yield even approaching 1 mg protein per 1 ml of reaction volume[78, 133]. Batch format CF 
reactions are ideal for throughput systems with small volumes as low as a few microliters. The set 
up and further processing of the reaction can then be handled via robots. The ‘Cytomim’ system was 
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used as a basic CF protocol in batch format as described [77]. Modifications are made in order to 
 
 Figure 9. Platform for high-throughput optimization of CF MP production. An integrated process for pipetting, 
incubation, separation, purification, and quantification. 
 
obtain the highest yield, less cost, and suitable for robot pipetting [57]. Basic compounds and the 
recommend optima concentrations are listed in Tab. 5. 
 
Table 5. list of all the compounds for batch CF reaction and with the recommended concentration range. 
Compound Stock   Final   
Premix 10 × 1 × 
Amino acid mix 8 mM each 2 mM each 
PEP 1 M 30-50 mM 
CoA-Na+ 30 mM 0.26 mM 
E. coli tRNA 40 mg/ml 0.17 mg/ml 
T7RNAP 1.4 mg/ml 10 µg/ml 
36 x NTP-Mix ATP: 90 mM 
C/G/UTP: 60 mM each 
ATP: 2.5 mM 
C/G/UTP: 1.7 mM each 
Plasmid template 0.2 - 0.5 mg/ml 0.002-0.015 mg/ml 
E. coli S30 extract 100% 24%-30% 
MilliQ water  fill up to final volume 
 
In the compound list, we introduced a premix (Tab. 6), which contains several standard 
compounds, in order to reduce the time for pipetting. Premix could be stored at -20
o
C and refrozen 
without detectable loss of efficiency. Extract, enzymes, unstable compounds and potential screening 
components were not included into the premix in order to keep options for further protocol 
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optimizations. Reaction volumes were miniaturized down to 25 µl in order to reduce cost but still 
allowing sufficient volume for screening compounds. The pipetting time of a complete 96-well 
micro-plate could be reduced to 30-45 min depending on the number of screening compounds and 
additives.  
 
Table 6. Compounds that contained in the premix. 
Compound                      Stock Final 
Putrescine 15 mM 1.5 mM 
Spermidine 15 mM 1.5 mM 
K+-glutamate 2500 mM 250 mM 
NH4
+
-glutamate 100 mM 10 mM 
Mg2+-glutamate 100 mM 10 mM 
Na+-oxalate 40 mM 4 mM 
Na+-pyruvate 330 mM 33 mM 
Folinic acid 340 µg/ml 34 µg/ml 
DTT 10 mM 1 mM 
NAD+ 5.3 mM 0.53 mM 
 
Folding of sGFP is oxygen dependent and the plates were incubated for 2 hours at 4 
o
C, 
after the reaction in order to allow sufficient time for folding of the monitor. 
4.1.1.2   Perform the CF protocol via robotic pipetting 
With established CF protocol, CF reactions can be then pipetted by the robot. However, 
several important parameters with regard to the liquid classes need to be considered and optimized 
for the robotic pipetting. Different liquid classes were defined as: diluent, ProteinExp and Protein 
ExpVisc. As each liquid requires due to its properties special handling features, we focused 
specially on the viscosity, which gives a major impact on velocities of aspiration and dispensing, 
introduction of air-gaps and excess volumes or the positioning of the tip relative to the liquid surface. 
So water was finally defined as diluent, medium viscous liquids as e.g. co-factors as ProtExp and 
very viscous or crucial liquids like premix, extracts, enzymes as ProteinExpVisc. 
In order to further reduce the time required for pipetting and also obtain reliable results of 
compounds screening. A mastermix (MM) has to be created, which contains all the components that 
are kept constant in each reactions of a screening. Then, the MM can be aliquoted into each well. 
Finally, the screening compounds were then pipetted. During all the pipetting process, the plate was 
kept at 4 
o
C on the cooled carrier. Normally, the NTP-mix is added in the final step to act as a 
reaction starter. After finishing pipetting, the microplate was sealed with Parafilm and incubated at 
30 
o
C, 9 Hz shaking speed on the TECAN incubator. 
In order to handle the complicated pipetting process, we introduced custom designed 
software to create the pipetting lists, which can be carried out by the TECAN software Gemini. All 
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the reagents with stock concentrations are stored in the reagent data base. When starting the 
program, all the reagent which are needed in the following experiment, are selected. Secondly, set 
up the final concentration of all the compounds. For the reagents that you want to perform a 
concentration screening, in this step, choose the highest concentration in the screening. Thirdly, 
assign the usage of all the compounds. In the current version, two screening compounds can be 
defined. The final concentration of two screening compounds can be programed to vary per row or 
per columns. At the same time, up to 4 additives can be selected. The additives are chosen to be 
added per rows. Additive 1 is reserved for the starter reagent. Normally, the NTP mix was used as 
starter. However, other reagent like DNA template can also be the starter reagent. 
4.1.2 Basic compounds screening  
With the established CF expression platform, two basic screening modes can be performed. 
One is linear screening, where the concentration of one compounds can be screening within certain 
range. Another is correlated screening, where the concentrations of two compounds can be screened 
at the same time. One is screened per row; the other is screened per column as shown in Fig. 10. 
 
Figure 10. CF expression protocol optimization by throughput linear and correlated compound screens. The 
expression of sGFP and small multidrug transporter SugE-sGFP has been analyzed. The screening compounds are 
indicated in the figure.  
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4.1.2.1 Linear screening of basic compounds using sGFP as a monitor 
In order to perform a fast determination of CF expression yields, a shifted green fluorescent 
protein (sGFP) was selected. The fluorescent measurement can be easily and accurately quantified 
and correlated with the protein concentration. Several critical basic compounds were selected and 
evaluated to determine their optima concentrations.  
 
Figure 11. Linear screening of the basic compounds of CF system. Each compound was screened according to the 
concentrations mentioned above while other compounds were kept with the optima concentration.  
To establish an expression protocol, several important compounds have to be optimized like, 
Mg
2+
, K
+
 and S30 extract. Here we select several compounds, which are not included in the premix, 
and further optimize them by using the linear screening function of the E.Y.E.S. program (Fig. 11). 
A major compound is the S30 extract and the optimal final concentration in the reaction was found 
at approx. 30% (Fig. 11). The Mg
2+
 optima of different S30 extract preparations can be different and 
the therefore a rescreening of the ion concentration was performed with each new S30 extract batch 
(Fig. 11).  
Reducing conditions could become critical depending on the structure of the synthesized 
target proteins. DTT as reducing agent is tolerated in the reaction from zero to 10 mM final 
concentration without significant effects and could thus be supplemented if necessary (Fig. 11). 
NH4
+
 titration from 1 to 30 mM had no effect on GFP expression.  
The template concentration always plays an important role in the final expression yield. Not 
only the quality of the template was important, but also the concentration of the template is crucial 
to the final expression yield. sGFP and soluble enzyme GNA1-sGFP were selected as example for 
the template concentration screening as shown in Fig. 12. The results showed that below 1 ng/µl the 
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expression yield is linear correlate with the template concentration. When the template 
concentration is above 2 ng/ µl, the yield of the CF reaction reached a plateau.  
 
Figure 12. Template concentration screening in batch CF system. Two targets sGFP and GNA1-sGFP were selected as 
model proteins.  
The usage of linear PCR product as DNA template great accelerates the whole preparation 
of CF reactions. In order to evaluate the difference between linear template and plasmid template, 
experiment with different concentration of linear template was performed. As shown in Fig. 13
 
Figure 13. Comparison of linear template and plasmid template in CF reaction systems. Different concentrations of 
linear template was used in CF system and compared with the plasmid concentration. Different linear template to plasmid 
template molar ratios are indicated in the figure.  
Several very sensitive parameters like Mg
2+
 concentration are recommended to be screening 
whenever changing reagents like extract and buffers. In the following experiment, two different 
batch of S30 extract was used and the Mg
2+
 concentration was screened. As shown in Fig.14, there 
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is a clear optimum concentration shift between the two batches of extract. A small change in the 
Mg
2+
 concentration may cause great reduction in the final protein yield.  
 
Figure 14. Comparison the optima Mg2+ concentrations of two different batches of S30 extract. 
Kinetic experiment of the batch CF expression system was performed and shown in Fig.15. 
Results shown that after 2 hours the expression is nearly finished. 
 
Figure 15. Kinetics of batch CF expression system. At different time point, reactions was stopped by lowing the 
temperature to 4oC for 1 hour, then the fluorescence of the reaction was measured and sGFP concentrations were 
calculated using standard curve.  
In order to test, if this optimized batch CF system can be easily scaled up without loss in the 
yield. We performed the following experiment with different volume. Volume range from 25 µl to 1 
ml was selected. The experiment was performed in 96-well plate and 24-well plate. 96-well v-
shaped plate was used when the volume is below 200 µl, while 24-well plate was used when the 
volume is above 200 µl. The result of this experiment indicated that simply scale up to 1 ml reaction 
volume will not decrease the efficiency of the expression system (Fig. 16). 
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Figure 16. Scale up of CF batch reactions into preparative scales. Reaction conditions for sGFP expression 
optimized in 25 µl volumes were stepwise scaled up to one ml reaction volumes. For reaction volumes ≤ 200 µl, 96-
well microplates were used. For reaction volumes ≥ 400 µl, 24-well microplates were used. 
 
4.1.2.2 Correlated screening of basic compounds using sGFP as a monitor 
In linear screening, the effect of individual compounds were evaluated, however, there are 
cases, where the concentration optima of several compounds could depend on each other. In this 
correlated screening, two compounds are screened at the same time. With the E.Y.E.S program, this  
Figure 17. Correlated screening of Mg2+ and NTP mix. 1 fold of NTP mix corresponding 
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Figure 18. Correlated screening of PEP and Mg2+. Different concentration of the two selected compounds were 
sleceted 
correlated screening can be easily achieved as shown in Fig. 8. Mg
2+
 and NTP mix are selected, as 
shown in Fig. 17. With certain concentration range, the increase of NTP mix concentration could be 
implemented by increasing Mg
2+
 concentrations. The optimum concentration for NTP mix in this 
screening is between 1 and 2 folds with Mg
2+
 between 20 and 26 mM.  Another example was PEP 
and Mg
2+
 (shown in Fig. 18); however, here the effect of PEP cannot fully be implemented by Mg
2+
. 
In this case, the highest expression yield was achieved with the fixed optimum concentration (PEP 
48 mM, Mg
2+
 26 mM) for these two compounds. 
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4.2 Systematic chemical compounds screening via throughput cell-free system 
There quite a large number of proteins which tend to form precipitate, soluble aggregation 
and mis-folded inclusion bodies when expressed in vivo. Well known class of protein was enzymes, 
which were quite sensitive to temperature, pH, and buffers. It was quite difficult for traditional in 
vivo expression system to produce such kind of difficult proteins and often results in low yield or 
non-functional mis-folded proteins. Therefore quite lots of studies were done to improve the 
stability of these unstable proteins. In natural environment, both prokaryotic and eukaryotic cells 
develop a strategy to protect their proteins by producing low molecular weight organic substance 
called osmolytes when subjected into harsh environmental conditions such high salts, cold and hot 
stress1. In addition, to apply such kind of low molecular compounds to the protein as soon as they 
were produced was quite difficult because of the cell wall and membrane barrier. As a result, those 
proteins often were expressed as inclusion bodies or aggregations in vivo. Later on, the mis-folded 
protein was refolded after a complete denaturation via harsh chemical reagent like urea or guanidine 
hydrochloride. The final ratio of successful refolded protein was often in a relative low amount.   
According to previous reports, different osmolytes (i.e., amino acids and their derivatives, 
polyols and sugars), PEG serious, PEI, betaine, ectoine and choline, behaving as protein stabilizers 
[134, 135], inducing refolding of misfolded proteins [136, 137] and removing protein 
aggregation[138-140], were selected for testing. However, those experiments were performed post-
translational; the effects of those chemical compounds on the CF expression system still need to be 
systematically evaluated. The effects were shown as co-translational level. Red shifted green 
fluorescence protein (sGFP) was chosen as model protein for fast quantification by fluorescence. 
Amount the selected osmolytes, three basic effects were observed, which we classified as positive, 
negative and tolerant. For positive effect, an increase of sGFP fluorescence was observed. For 
negative effect, the CF system was killed or terminated with very low concentration of certain 
compounds. With tolerant effect, the fluorescence of sGFP decreased with the increase 
concentration of added compounds.  
In order to exemplify the application of those compatible chemical protein stabilizers, we 
choose two targets from our lab, which are difficult to expression and tend to form precipitate and 
aggregation. One is Halogenase, which is the first enzyme within the biosynthesis of curacin A (a 
bioactive compound with potent anti-proliferative activity) pathway. The biosynthesis of CurA is 
mediated by a 2.2 MDa hybrid polyketide synthase (PKSs) and non-ribosomal peptide synthetases 
(NRPSs) as shown in Fig. 19. Another target we select was the human GNA1 (EC 2.3.1.4) catalyzes 
the transfer of  the Acetyl group from Acetyl Coenzyme A (AcCoA) to the primary amine of D-
glucosamine-6-phosphate to form N-acetyl-D-glucosamine-6-phosphate (GlcNAc-6P) and 
Coenzyme A (CoA)[141, 142]. 
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Figure 19. Ten-enzyme assembly catalyzing the cyclopropane ring formation. (a) The 10 enzymes that are involved in 
the cyclopropane ring formation are encoded on different proteins. (b) Representation of the biosynthesis of the 
cyclopropane ring formation. GNATL = loading module, KS = ketosynthase, AT = acyltransferase, Hal = halogenase, 
ACP = acetyl-carrier-protein, HCS = HMG-CoA synthase-like enzyme, ECH1 = dehydratase, ECH2 = decarboxylase, ER 
= enoyl-reductase 
4.2.1 Linear screening of chemical compounds using sGFP as monitor 
sGFP was used as monitor to see if the selected chemical compounds can be tolerant or 
beneficial effect on the CF system. The fluorescence of sGFP was used as a quantification method 
for protein quantification. 
4.2.1.1 Effect of alcohols 
Alcohols, due to their hydrophobicity, help for stabilizing MP and are often used in 
crystallization studies. In this experiment, different alcohols were select from methanol to hexanol, 
the effect on the expression of sGFP was shown in Fig. 20. In addition, we reduced the Mg
2+
 
concentration and performed the same experiment to see if the effects of the alcohols on sGFP are 
dependent on the Mg
2+
. As shown in Fig. 20, different effects were observed for different alcohols. 
Methanol, isopropanol and butanol are tolerant by the system to certain concentrations. The 
expression yield decreased linearly with the increase those three alcohols. Ethanol was found to 
have even a beneficial effect on the expression with up to 60% more if compared to the control. In 
contrast, pentanol and hexanol immediately killed the CF system with very low concentration.  A 
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similar experiment was performed with lower Mg
2+
 concentration. The effects were the same as 
compared to the optima Mg
2+
, except for the case of ethanol. The expression yield was increase 
much more up to 300% compared to the control.  
 
4.2.1.2 Effect of sugars and polyols 
Several commonly used sugars and polyols, including sucrose, glycerol and D-trehalose and 
so on are selected for this experiment. The effects of these compounds are listed in Fig. 21. As 
shown in the figure, this type of chemicals behaves in the CF expression system quite similar. The 
expression yield of the sGFP in CF system linearly decreased with the increasing concentration of 
the tested sugars and polyols. However, CF system showed better tolerance to sucrose than all the 
others. With up to 10% sucrose the CF system still reserved 80% of the expression yield. 
Figure 20. The effects of 
different alcohols on the 
expression of sGFP. The 
control without any alcohol 
is taken as 100%. The 
concentration range of each 
alcohol is from 0-15% 
(w/v). 
A: Within this screening all 
the compounds are set up 
with their optima 
concentrations. Alcohols 
are screened with changes 
in their final  
concentrations in the CF 
expression system. 
 
B: In this screening, the 
Mg2+ concentration was 
reduced compared to the 
optimum concentration. In 
the control reaction without 
any alcohol, the expression 
of sGFP was lower than 
that control in (a).  
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Figure 21. Effect of different sugars and polyols on CF expression of sGFP. The screening range of the corresponding 
chemicals is from 0-10% (w/v). 
4.2.1.3 Effect of betaine and other natural osmolytes 
Natural osmolytes are known to be effectively protected the cells and proteins under 
extreme conditions like: high salt, high temperature, high pressure and so on. We selected several of 
them except those sugars and polyols to be tested in the CF system. As shown in Fig. 22, betaine 
and ectoine both showed a very high tolerant concentration range. Up to 200 mM for betaine, 150 
mM ectoine, more than 80% of the expression yields were obtained. With choline, there is even a 
beneficial effect on the expression, around 30% more expression yield was achieve with around 10 
mM choline.  
 
Figure 22. Effect of several natural 
osmolytes on CF expression of sGFP. 
The screening range of the 
corresponding chemicals is indicated in 
the figure with unit of mM. 
 
4.2.1.4 Effect of amino 
acids 
Amino acids and their 
derivatives are also known to be 
one class of osmolytes. They 
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also greatly stabilized certain kind of protein. Well known is Arginine, which is frequently used in 
buffers to stabilize protein after expression and isolation. Here we selected several of them to be 
tested in the CF expression system, including L-agrinine, N-acetyl-L-Lysine, L-Carnitine, Sarcosine, 
trans-OH-L-Proline. A buffer system of 200 mM HEPES, pH 8.0 was used when the pH of certain 
compounds is not neutral. As shown in the following figure, nearly all the amino acid showed a 
slightly beneficial effect on the sGFP expression. 
 
 
Figure 23. Effect of several amino acids and their derivatives on CF expression of sGFP. The screening range of the 
corresponding chemicals is indicated in the figure with concentration unit of mM. 
4.2.2 Correlated screening of two compounds using sGFP 
PEG was frequently used molecular crowding reagent and PEG8000 was used in several CF 
expression systems to mimic the in vivo environment. We select all the PEGs and test their effect on 
this batch CF expression system. As mentioned in the basic screening of batch CF system above, 
two compounds may interact with each other when used together. In this experiment, different Mg
2+
 
concentration (low and high) and one other compound were selected to perform the screening.  
At 20 mM Mg
2+
 concentrations, PEG slowly reduces the expression efficiency starting from 
2% final concentration after an initial slightly increase. At the lower 14 mM Mg
2+
 concentration the 
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effect is reversed and the expression efficiency is rapidly increased with a peak at concentrations of 
approx. 4% PEG. This observation can be explained by the general effect of PEG to attract water 
thus making other reaction compounds more readily accessible. 14 mM Mg
2+
 was suboptimal 
conditions and the increase in available Mg
2+
 ions rapidly increases expression efficiencies until the 
optimum in between 20-22 mM is reached. Vice versa, at the already almost optimal Mg
2+
 
concentration of 20 mM, the additionally available Mg
2+
 ions result into an excess that again 
decreases the expression efficiency. PEG therefore substitutes for part of the Mg
2+
 ions and vice 
versa, increased Mg
2+
 concentrations make PEG addition dispensable. 
 
Figure 24. Effect of PEGs in the expression of sGFP. Different Mg2+ concentrations (16 mM, 26 mM)was used in A, 
B. 
A 
B 
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In the following table we summarized all the results of the chemical stabilizer screening for sGFP in 
batch CF expression system, screening concentration range of each compound was given and the 
effect of the compounds also given as positive, negative and tolerant (Tab. 7).  
 
Table 7. Effects of different chemical compounds on the CF expression of sGFP 
Compounds Concentration range Effect Optimum/ Tolerant concentration  
Methanol 1-15% T 5.6% 
Ethanol 1-15% P 3.75% 
Isopropanol 1-15% T 3.75% 
Butanol 1-15% T n.a 
Pentanol 1-15% N n.a 
Hexanol 1-15% N n.a 
Glycerol 1-10% T 4% 
D-sorbitol 1-10% T 4% 
D-trehalose 1-10% T 4% 
Sucrose 1-10% T 10% 
D-mannose 1-10% T 2% 
Betaine 0-200 mM T 250 mM 
Ectoine 0-200 mM T 150 mM 
Choline 0-20 mM P 10 mM 
L-Glutamic acid 0-100 mM P 50 mM 
Trans-OH-L-Proline 0-10 mM P 5 mM 
L-Arginine 0-20 mM P 10 mM 
N-acetyl-L-Lysine 0-100 mM P 100 mM 
L-Carnitine Cl 0-30 mM P 5 mM 
Sarcosine 0-40 mM P 40 mM 
4.2.3 Stabilizer screening for better soluble expression of GNA1 and Halogenase 
4.2.3.1 Linear screening of potential chemical stabilizer for GNA1 and Halogenase 
Two soluble proteins GNA1 and halogenase, which form precipitate either in vivo or in 
vitro, were selected as models for testing the effect of the above mentioned compounds. sGFP 
fusion of GNA1 was made for fast soluble expression quantification. We select several compounds 
for the first screening as shown in Fig 26. In order to confirm if the fluorescence signal is correlated 
with the enzymatic activity of GNA1-sGFP, a functional assay was performed in parallel as shown 
in Fig 25. The results showed that the fluorescence signal was not always correlated with the 
enzymatic activity. Like the case of Trehalose, especially L-Arginine, the increase of fluorescence 
does not finally results in the same increase of enzymatic activity. This might due to the fact that 
these reagents are beneficial for the folding of sGFP. However, in the case of choline, both the 
fluorescence and enzymatic activity were increased by 20%.  
Further experiment was performed to compare the total protein concentration, fluorescence 
signal (which we consider as soluble folded sGFP) and the enzymatic activity of the GNA1-sGFP as 
indicated in Fig.27. The reaction mixture of the CF expressed GNA1-sGFP was dialysis against 
enzymatic buffer, and then used for enzymatic assay. Positive control without any additives and 
negative control without any DNA template were made for each screening experiment. As shown in 
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Fig. 27, addition of choline gave an increase of around 20% percent soluble expression, 7% increase 
of total protein expression, and 20% increase of enzymatic activity. However, in the case of 
Arginine, the increase of fluorescence did not result in the increase of enzyme activity. The total 
protein expression was reduced by 8%, which was consistent with around 8% decrease in the 
enzymatic activity. This experiment confirmed that Arginine might have a beneficial effect on the 
folding of sGFP but not the GNA1. 
 
Figure 25. Effect of selected chemical stabilizers on the soluble expression and enzymatic activity of GNA1-sGFP.  
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Figure 26. Effect of selected chemical stabilizers 
on the soluble expression of GNA1-sGFP. All the 
chemicals was added with the final concentration 
indicated in the figure. In case of charged 
compounds like choline and Arginine which 
affect the pH, a HEPES buffer system was used 
with additional glutamic acid. 
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Figure 27. Effect of Choline and L-Arginine in the total protein expression, fluorescence of sGFP and GNA1-sGFP 
and enzymatic activity of GNA1-sGFP.F: Fluorescence; T: Total protein concentration measured by radioactive labeling; 
E, enzymatic activity.  
Another experiment with Halogenase was performed. Result for halogenase was shown in 
Fig. 28, soluble fractions was collected after expression and applied on to western blot for 
quantification. Results showed that choline and arginine gave increase of around 20% and 10% in 
soluble expression. 
 
 
Figure 28. Screening of several compounds on the soluble expression of Halogenase. M, molecular marker; P, 1, 2, 3, 
4  represent: positive control for quantification (Positope™, invitrogene), control, 6% Trehalose, 10 mM Arginine, 10 mM 
Choline. The band intensity was used to quantify the protein concentration by quantity one (Bio-Rad).Sample was 
collected after 2 hours expression and transferred into eppendorf tubes. After centrifuge at 22,000xg  for 10 min, 2 µl of 
supernatant was used for western blotting. 5 µl of positope was loaded.The results was normalized taken control as 100%, 
which corresponding to protein concentration of 80 ng/µl (calculated by comparison with Positope). The normalized data 
were: 100%, 73.3%, 108%, 125% for lane 2-5. 
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4.2.3.2 Correlated screening of PEG and choline for GNA1-sGFP 
In order to check if the beneficial of two stabilizers or expression enhancer had a 
accumulative effect on the specific target, GNA1-sGFP was chosen and subject into the correlated 
screening. Two compounds, PEG8000 and choline, were selected for this experiment. As shown in 
Fig. 29, the beneficial effect of PEG8000 and choline is accumulative, which is better than using 
one of them alone. There was more than 100% increase in the fluorescence than the control without 
any chemical compounds. By using PEG8000 and choline alone, there was around 30% increase in 
the fluorescence. However, when using together, the increase was more than 60%, but more than 
100%. This result showed that not only accumulative beneficial effect was observed, but also a 
beneficial increased beneficial effect was achieved. 
 
 
Figure 29. Correlated screening of PEG8000 and choline for the soluble expression of GNA1-sGFP. 
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4.3 Application of throughput cell-free expression system on membrane 
proteins 
Sufficient yield in combination with high quality of the target MP are the two key 
benchmarks which have to be approached by a multiple screening strategy. Fast and efficient 
monitoring systems would be helpful in order to accelerate protocol development. Derivatives of 
green fluorescent protein (GFP) have been proposed as expression and folding monitor for MPs 
synthesized in cellular systems [143]. In MP-GFP fusions, the C-terminal GFP moiety appears to 
have even sometimes a correlated folding behavior with the attached MP. GFP fusions could thus be 
used (I) for monitoring of MP expression rates, (II) as preliminary folding indication of the attached 
MP and (III) for fast tracking and establishing MP purification protocols.  
For the implementation of GFP as monitor in CF systems different aspects have to be 
considered. In the P-CF mode, the synthesized MP should not be able to fold into functional 
conformations as no hydrophobic environments for its stabilization are present. The MPs therefore 
instantly precipitate and consequently direct the attached GFP into the pellet. If the folding of the 
two partners in the MP-GFP fusion is correlated, the precipitated GFP should be non-fluorescent, 
which indeed is usually the case [144]. 
4.3.1 D-CF expression of membrane proteins using different sGFP derivatives fusion 
as expression and folding monitor 
In the D-CF mode, detergents are supplied which instantly solubilize the freshly translated 
MP-GFP fusions into micelles. The functional folding of a number of MPs after expression in the 
D-CF mode has already been shown [145, 146]. However, unfortunately the folding of GFP is 
specifically affected by the presence of detergent [102]. In many commonly used detergents such as 
DDM, Digitonin or Triton X-100, the folding of GFP is almost completely abolished resulting in 
only low fluorescence signals (Fig. 30). Only in the mild detergents Brij-58, Brij-78, Brij-98, in the 
amphipol Nvoy10 and in decyl-MNG 30% - 60% of the fluorescence signal can be recovered while 
the rest of the GFP fraction remains in a non-fluorescent conformation. The detergent induced GFP 
misfolding is non-reversible and the protein stays non-fluorescent after detergent removal. However, 
once folded, GFP is highly resistant against unfolding in presence of a large variety of detergents 
[57, 102]. Nevertheless, the residual activity of GFP can still be sufficient for throughput expression 
screening in the D-CF mode as shown with the CF expression profiling of a library of E. coli inner 
MPs [102]. However, future applications might rather implement the recently developed derivative 
superfolderGFP having improved stability [147]. The overall detergent resistance of 
superfolderGFP is significantly increased and recovery of fluorescence signals exceeded 70% with 
most analyzed detergents.  
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In order to test the detergents tolerance of these two different GFP derivatives, experiment 
was performed using sGFP and superfolderGFP as template in the CF expression system in presence 
of different detergents. After expression, the fluorescence of the CF reactions was measured. As 
indicated in Fig. 30, the comparison of sGFP and superfolderGFP with most commonly used 
detergent for MPs in CF expression systems showed that the detergents compatibility of 
superfolderGFP was much better than that of sGFP, which only showed good folding in Brij 
detergents and Decyl-MNG. In contrast, superfoderGFP showed much better tolerance to different 
kind of detergents in CF systems. Even those detergents like TritonX-100 and DDM which are not 
suitable for D-CF expression with MP-sGFP fusions are now possible to use with superfolderGFP 
fusion.  
 
Figure 30. Comparison the folding of sGFP and superfolderGFP in presence of detergents via CF expression 
systems. Concentrations shown in percentage were w/v. Control was performed without any detergent and was taken as 
100% for the normalization. 
 
Further experiment with a MP target was performed. SugE, which is a small multidrug 
transporter, was used as a model protein. Different constructs with sGFP or superfolderGFP fusion 
in the C-terminal of the SugE gene were made. Then, these two construct were used in the CF 
expression with different detergents. After expression, the supernatants of the CF reaction mixtures 
were used for fluorescence measurement. As shown in Fig.31, SugE-superfolderGFP showed quite 
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good fluorescence signal in many detergents, including Brij-35, Brij-78, Brij-58, Digitonin, Laury-
MNG, and Decyl-MNG. In contrast, SugE-sGFP only showed good fluorescence signal in Brij-78 
and Brij-58. This experiment gave the idea that D-CF expression of MPs using the GFP as monitor 
is largely depending on the folding of GFP itself. In quite some cases, the MPs can be expressed as 
soluble form in certain detergents, which were not tolerant by the fusion GFP. 
 
 
Figure 31. Comparison of the cell free produced SugE-sGFP and SugE-superfolder GFP in presence of different 
detergents. The fluorescence signal was normalized and the value of SugE-sGFP and SugE-superfolderGFP in Brij-78 
was set up as 100%. Control sample was performed without any detergent. Detergent concentrations shown in percent 
were all w/v. 
 
4.3.2 Improving MPs translocation with lipid/detergent mixtures 
In L-CF mode approaches, detergents are only present if initially bicelles or lipid/detergent 
mixtures are supplied into the RM. In contrast to detergents, lipids generally do not seem to have 
negative effects on the folding of GFP. However, some lipids might have negative effects on the 
protein expression efficiency depending on the supplied concentration. While transcription appears 
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to mostly benefit from the presence of different types of liposomes, the translation was enhanced by 
anionic and neutral liposomes and inhibited by cationic liposomes [92]. GFP fluorescence of MP-
GFP fusions can certainly only taken as first indication of MP folding which requires further 
subsequent verification by specific assays in each individual case. A relatively fast approach is the 
analysis of L-CF synthesized proteoliposome with confocal microscopes which could indicate the 
co-localization of the MP-GFP fusion with the liposomes [148]. 
Complete or partial solubilization of lipid bilayers by detergents could improve their 
availability and interaction with synthesized MPs. Corresponding Lipid/detergent mixtures are 
prepared in vitro in fixed ratios (Tab. 8) and they can be implemented for the soluble CF expression 
of MPs in two different approaches. One strategy is to add a certain amount of detergent only into 
the RM in order to initially solubilize the supplied lipids. During incubation, the detergent will than 
constantly be diluted out from the RM by diffusion into the FM. The kinetics of dilution will depend 
on the specific CMC and micelle size of the detergent. Mixtures of lipids and detergents form water-
soluble assemblies most likely containing solubilized individual lipids as well as variable patterns 
and stretches of solubilized bilayers. The first six hrs of CECF reactions are most productive and 
some 80% of the final MP will be synthesized during that time [149]. The detergent will support the 
solubilization of the synthesized MPs and could promote their association with the solubilized lipids. 
During progress of the reaction, the detergent concentration will constantly be reduced and the 
forming liposomes may include the associated MPs. With this approach, a better folding of 
bacteriorhodopsin was obtained if initialyy steroid detergents such as cholate, CHAPS or digitonin 
have been provided [149].  
Alternatively, the detergent concentration can be kept constant by its addition in RM and 
FM. Relatively well analyzed are bicelles formed by mixtures of DHPC and DMPC and consisting 
of central lipid discs surrounded by the detergent [150]. For preparing bicelles, the lipids ratio, q 
(the molar ratio of long- to short chain lipids or detergent) is crucial for the size of bicelles and need 
to be optimized for specific MP targets [151]. One of the most important parameter for structural 
studies is the stability of the samples. MPs in bicelles tend to precipitate with halftimes of some 3-4 
days for q = 0.33 bicelles. One reason for this instability could be ester hydrolysis of phospholipids. 
This can be solved by using the more stable ether-linked analogues of DMPC and DHPC [152]. 
Another alternative solution is introducing a fraction of negative charged phospholipids, which will 
increase the repulsion between bicelles and minimize protein aggregation [153]. Several MPs like 
ATP synthase, bacteriorhodopsin were functionally L-CF produced in presence of bicelles [149, 
154]. In addition, recent studies showed that NMR analysis of MPs in bicelles is feasible [153, 155, 
156]. 
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Table 8. Preparation of lipid/detergent mixtures for L (D)-CF expression approaches 
Lipid Detergent Detergent conc. (%)
1
 Lipid:detergent 
molar ratio 
DMPC  
(4 mg/ml) 
CHAPS 0.15 2.42 
 Digitonin 0.5 1.45 
 Triton-X100 0.25 1.56 
 Brij-35 0.04 17.70 
 Brij-78 0.2 3.40 
 DPC 0.2 1.03 
 DDM 0.5 0.59 
DMPC  
(10 mg/ml)
2
 
DHPC 2 0.36 
Egg PC  
(6.7 mg/ml)
3
 
β-OG 1 0.25 
 Triton X100 0.03 18.77 
 DDM 0.02 22.23 
 Brij-58 0.02 48.90 
 Digitonin 0.2 5.35 
 Cholate 1 0.37 
 CHAPS 1 0.54 
 Deoxycholate 0.5 0.72 
 PFO 2 0.18 
 Lauryl sarcosine 1 0.26 
 SDS 0.5 0.50 
1, concentrations necessary for complete lipid solubilization 
2, concentrations for bicelle formation [154]. 
3, [149] 
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4.4 Expression, purification and optimization of membrane proteins for 
functional and structural analysis  
4.4.1 Investigation on the small multidrug resistance protein-SugE 
Small multidrug resistance (SMR) proteins are integral MPs, located within the plasma 
membrane of most Bacteria and Euryarchaea [157], that confer resistance to quaternary cation 
compounds (QCC) via proton motive force [158]. As indicated in the name, these small (~12 kDa) 
integral inner MPs range from 100 to 140 amino acids in length, 4 α-helix transmembrane strands 
(TMS) [159]. Different from other multidrug transporter protein, the SMR family has only been 
proved transport of lipophilic compounds, primary QAC and a variety of antibiotics [158, 160, 161].  
The SMR protein family is composed of three major protein subclasses: small multidrug 
proteins (SMP), suppressor of groEL mutations (SUG), and paired SMR proteins (PSMR). Among 
the three SMR subclasses, only SMP and SUG subclass members are capable of conferring isogenic 
QCC resistance to its host and members from either subclass are frequently encoded in conserved 
regions of integrons [162, 163] and on multidrug resistant plasmids [164, 165]. The narrow QCC 
spectrum of SugE is limited to antiseptics, specifically those with one or more elongated acyl chain 
R groups that range from C12 to C18 covalently bound to a single N cation [166]. More specifically, 
SugE can confer host resistance to the antispectics, cetylpyridinium (C21H38N), cetyldimethylethyl 
ammonium (C20H42N), and hexadecyltrimethyl ammonium (C19H42N) also known as cetrimide [166]. 
4.4.1.1Sample preparation of SugE produced in cell-free system 
With the goal of functional and structural investigation of CF produced SugE, different CF 
expression strategies were applied to obtain large amount of pure protein sample in a soluble form. 
After first optimization of the basic conditions like Mg
2+
 and K
+
, an expression yield around 2 mg 
per 1 ml reaction mixture of native SugE from E. coli without any tags was obtained in the P-CF 
mode. In order to resolubilize the pellet of SugE, different detergent was selected. According to the 
previous results, a two-step resolubilization strategy was used. Pellet sample from the reaction 
mixture was firstly washed with 20% NDSB256, which found to solubilize the co-precipitate protein 
not SugE [81]. Finally, the SugE could be efficiently resolubilized in 2% DDM, when incubated for 
2 hours at 37
o
C with shaking. Further experiment was performed with the commonly used 
detergents like β-OG and TritonX-100. These two detergents showed good selectivity, however, 
there were still relative large amount of proteins still remained in the pellet form after detergents 
treatment. As shown in Fig. 32, with 5% TritonX-100, SugE was selective resolubilized with very 
few impurities. However, still quite a lot of SugE protein remains in the pellet form. The same effect 
was observed for β-OG resolubilization.  
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            Different resolubilized 
samples were checked by 
SEC, the results were shown 
in Fig. 33. From the results, 
the NDSB256 washed and 
DDM resolubilized sample 
gave the best peak shape, 
indicating the best sample 
homogeneity. However, β-OG 
directly resolubilized sample 
showed a very broad peak, 
while TritonX-100 showed a 
medium quality in the peak 
shape. 
 
 
Figure 33. Elution profiles of detergent resolubilized SugE sample on a Superdex 200 10/300 gel filtration colume. 
4.4.1.2 Sample preparation of SugE for crystallization trials 
In order to prepare the sample for crystallization, a stable and homogenous sample with 
high concentration was required. The protein sample was concentrated via a centricon centrifugal 
filter device. Concentration was performed step by step and sample was taken for each step and the 
protein concentration was measured. The concentrated sample was checked by Tricine-SDS- PAGE 
as shown in Fig. 30. The concentrated sample was store at 4
o
C to check the stability. Results 
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Figure 32. Tricine-SDS-PAGE of TritonX-100 resolubilized SugE. SguE were separated by Tricine-SDS-PAGE 
(12%). M: Protein marker; C, Control pellet without any detergent treatment. P, pellet after detergent treatment; S, 
supernatant after detergent treatment.Percentage shown on top was w/v. 
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showed that the concentrated sample was stable at 4
o
C with concentration around 10 mg/ml. The 
sample of SugE already started to precipitate after stored at 4
o
C for 2 days at the concentration of 15 
mg/ml. 
Since there were still quite some impurities in the resolubilized sample and there are no 
affinity tags in this protein construct, a further semi-preparative scale SEC was performed in order 
to purify the SugE 
protein sample. 
Resolubilized SugE 
protein sample in 2% 
DDM was loaded on 
to the Superdex 200 
10/300 column. As 
indicated in Fig. 35 
after collecting the 
SugE protein peak 
fraction, the SDS-
PAGE showed a 
better purity 
compared to the 
loaded sample in Fig. 
34. The collected 
sample from the 
semi-preparative gel 
filtration column 
was pooled and 
concentrated again 
to the concentration 
around 10 mg/ml. 
 
 
Figure 34. Tricine-SDS-PAGE of concentrating the resolubilized SugE sample in 
2% DDM using a Centricon centrifugal filter device. The starting volume was 1.2 ml 
resolubilized SugE with a protein concentration around 1.6 mg/ml. The flowthrough from 
the filter device was also loaded on the gel to check if there are SugE samples in it. The 
volumes indicated in the labeling were the final volume remained after concentrating. 
And the volume in the brace was the volume of concentrated sample that was loaded on 
to the gel. M, Protein marker. 
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Figure 35. Profile of concentrated SugE samples in DDM on a Superdex 200 10/300 semi-preparative colume. 
Arrow indicated peak fraction was collected, pooled, and analyzed by gradient SDS-PAGE gel. Running buffer contained 
0.05% DDM 
Detergents were known to be important for MPs crystallization. Therefore, the experiment 
was performed to check if SugE protein was stable and homogenous in other commonly used 
detergents. Since the construct currently using was without any affinity tags, the detergent exchange 
was performed on the gel filtration column, which was pre-equilibrated with the exchange detergent. 
Maltosides and glucosides with different Alkyl chains were chosen because previous result showed 
that SugE stay stable in DDM and β-OG. SEC elution profile of SugE detergent exchange was 
shown in Fig. 36, results showed that NG, DDM, C8E5 and C10E5 gave the best SugE peak shapes, 
which indicated homogenous samples. 
Stability test was performed in 4
o
C, SugE samples only showed good stability in DM and 
DDM. In other detergent, SugE protein started to precipitate within 1-3 days. Therefore, we chose 
the sample in DDM and DM for the first crystallization trials. 
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Figure 36. Detergent exchange on a SEC using Superdex 200 3.2/30 gel filtration column. Resolubilized SugE 
samples in 2% DDM was loaded on to the gel filtration column, pre-equilibrated with the indicated secondary detergent. 
The running buffer only differed in the corresponding detergent: 2% FG, 0.3% NG, 0.9% β-OG, 0.4% NM, 0.25% DM, 
0.05% DDM, 0.3% C8E5, and 0.05% C10E5. The black arrow indicated the void volume and the red arrow indicate the 
SugE protein peak. 
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Several commercial MP crystallization kits were used for the first condition screening and a 
custom designed pH screening was performed. Results showed that SugE was quite stable from pH 
5.1 to 9.1, no significant precipitation was observed. There are several conditions, which showed 
microcrystals, as shown in Fig. 37. However, when check by X-ray they are all detergent crystals 
not protein. 
 
Figure 37. Crystallization conditions where microcrystals appeared.  
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4.4.2 Preparative scale production of functional mouse aquaporin 4 using different 
cell-free expression modes 
The continuous progress in the structural and functional characterization of aquaporins 
increasingly attracts attention to study their roles in certain mammalian diseases. Although several 
structures of aquaporins have already been solved by crystallization, the challenge of producing 
sufficient amounts of functional proteins still remains. CF expression has emerged in recent times as 
a promising alternative option in order to synthesize large quantities of MPs, and the focus of this 
report was to evaluate the potential of this technique for the production of eukaryotic aquaporins. 
We have selected the mouse aquaporin 4 as a representative of mammalian aquaporins. The protein 
was synthesized in an E. coli extract based CF system with two different expression modes, and the 
efficiencies of two modes were compared. In both, the P-CF (CF MP expression as precipitate) 
mode generating initial aquaporin precipitates as well as in the D-CF (CF MP expression in 
presence of detergent) mode, generating directly detergent solubilized samples, we were able to 
obtain mg amounts of protein per ml of CF reaction. Purified aquaporin samples solubilized in 
different detergents were reconstituted into liposomes, and analyzed for the water channel activity. 
The calculated Pf value of proteoliposome samples isolated from the D-CF mode was 133 µm/s at 
10
o
C, which was 5 times higher as that of the control. A reversible inhibitory effect of mercury 
chloride was observed, which is consistent with previous observations of in vitro reconstituted 
aquaporin 4. In this study, a fast and convenient protocol was established for functional expression 
of aquaporins, which could serve as basis for further applications such as water filtration. 
4.4.2.1 Development of cell-free expression protocols for the preparative scale production of 
mAQP4 M23.  
Previously described CECF reaction conditions were used as criteria for the expression 
protocol development [145]. The first 22 codons are not essential for the mAQP4 water transport 
activity and thus were deleted in our construct [167, 168]. The mAQP4 M23 coding sequence was 
cloned into the vector pIVEX2.3MCS and the template was designed for the production of a 
modified mAQP4 M23 containing an additional 12 amino acid N-terminal T7-tag as well as a 
poly(His)10 purification-tag at the C-terminal end. The calculated molecular mass of this mAQP4 
M23 derivative is 30 kDa. Critical parameters for CF protein production are optimal ion 
concentrations in particular of Mg
2+
 and K
+
. After screening of Mg
2+
 and K
+
 ion concentrations in 
the P-CF expression mode in a range between 7 – 25 mM and 200 – 400 mM, respectively, optima 
were determined at 17 - 22 mM Mg
2+
 and 250 - 340 mM K
+
. With these conditions, the yield of CF 
produced mAQP4 M23 in 50 µl analytical scale micro-reactor reactions as well as in 3 ml 
preparative scale maxi-reactor reactions were routinely in the range of 1.5 - 2 mg protein per one ml 
RM.  
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4.4.2.2 Production of mAQP4 M23 proteomicelles in the P-CF and D-CF expression modes. 
In the P-CF mode, the mAQP4 M23 precipitated directly after translation within the RM. 
The precipitates were harvested by centrifugation, washed once with resolubilization buffer (20 mM 
Tris, pH 7.3, 150 mM NaCl) and instantly resuspended in a variety of detergents for resolubilization, 
with the same volume as the initial RM volume. For this P-CF resolubilization screen, the 
detergents Fos-12 (1%), DHPC (2%), Fos-16 (2%), LMPG (2%) and LPPG (1%) were evaluated. 
The initial suspensions were incubated at 37
o
C for 1 hour with gentle shaking to allow efficient 
mAQP4 M23 solubilization. Residual mAQP4 M23 precipitate was then removed by centrifugation 
at 18,800 x g for 10 min. The supernatant and residual pellets were subsequently analyzed by SDS-
PAGE, western blotting and immunodetection of the C-terminal poly-(His)10-tag. From tested 
detergents, 1% Fos-12, 2% Fos-16 and 1% LPPG showed optimal solubilization of the target protein. 
Nearly all precipitates were redissolved (Fig. 38), whereas 2% LMPG and 2% DHPC could only 
partially solubilize the mAQP4 M23 precipitates and approx. 50% of the protein still remained non-
soluble (Fig. 38).  
  
Alternatively, soluble 
mAQP4 M23 was directly produced in the D-CF expression mode. The detergents supplied into the 
RM provided hydrophobic environments for the co-translational solubilization of CF expressed 
mAQP4 M23. A number of D-CF suitable detergents including Brij-35 (polyoxyethylene-(23)-
lauryl-ether) (0.1%, w/v), Digitonin (0.4%, w/v), Triton X-100 (0.1%, w/v) and Tyloxapol (0.05%, 
w/v) were screened for their efficiency (Fig. 39). In the ideal case, all produced mAQP4 M23 
Figure 38. Resolubilization screening 
of P-CF produced mAQP4 M23.  
The pellet from the P-CF reaction 
mix was resuspended with 1% (w/v) 
Fos-12, 2% (w/v) DHPC, 2% (w/v) 
Fos-16, 2% (w/v) LMPG, or 1% 
(w/v) LPPG. Sample volumes of 4 µl 
were analyzed by 16% SDS-PAGE. 
The solubilization efficiency was 
determined by densitometry after 
immunoblotting using anti-His 
antibodies. Control is P-CF 
expressed mAQP4 M23. 
A: immunoblotting using anti-His 
antibodies. S, supernatant; P, pellet 
B: The solubilization efficiency 
determined by densitometry of the 
immunoblotting 
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should become soluble while the expression efficiency should not be reduced by the detergent. The 
detergents Brij-35 and Digitonin showed high efficiency to solubilize mAQP4 M23 without 
significant effect on the protein expression. With 0.2% Brij-35 in the RM, almost 90% of the 
expressed mAQP4 M23 was solubilized in proteomicelles. In the presence of 0.4% Digitonin, 
approximately 75% of synthesized mAQP4 M23 was solubilized. However, Triton X-100 (0.1%) 
and Tyloxapol (0.05%) were much less effective on the co-translational solubilization of mAQP4 
M23, with efficiencies of not more than 10%.  
 
4.4.2.3 Purification of mAQP4 M23 and in vitro liposome reconstitution  
Depending on the C-terminal poly-(His)10-tag, a one-step IMAC purification was applied to 
get relative pure proteins from both P-CF and D-CF mode samples (Fig. 40). Binding of mAQP4 
M23 to the IMAC column was relatively strong in the analyzed detergents Fos-12 (1%), Fos-16 
(2%), LPPG (1%) and Brij-35 (0.2%) and no elution was detected below 100 mM imidazol. Most 
impurities were washed off with 80 mM imidazol and the bound protein was eluted with 300 mM 
imidazol.  
The SDS-PAGE indicates a prominent 30 kDa signal as the mAQP4 M23 monomer. An 
additional protein band at 66 kDa detected by immunoblotting could correspond to mAQP4 M23 
Figure 39. Detergent screening 
of mAQP4 M23 expressed in 
the D-CF mode.  
A: RM samples of 2 µl were 
analyzed by 16% SDS-PAGE 
and immunoblotted using anti-
His antibodies.  
B: Solubility of D-CF expressed 
mAQP4 M23 in presence of 
0.2% Brij-35, 0.4% Digitonin, 
0.1% Triton X-100, and 0.05% 
Tyloxapol. Control is P-CF 
expressed mAQP4 M23. S, 
supernatant; P, pellet. 
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dimeric complexes (Fig. 40). After immobilization of mAQP4 M23 to the Co
2+
 loaded IMAC 
column, detergents used for the initial solubilization of mAQP4 M23 could be exchanged by 
secondary detergents. Only a limited number of detergents are suitable for D-CF expression or for 
resolubilization after P-CF expression. While the D-CF mode requires very mild detergents, for the 
resolubilization of P-CF produced precipitates only relatively harsh detergents are useful. Those 
detergents used for the initial MP solubilization might not be optimal for subsequent assays and 
exchange against a second probably better suitable detergent could be beneficial. To test the 
possibility of primary detergent substitution of mAQP4 M23, Brij-35 in the proteomicelles of D-CF 
expressed mAQP4 M23 was exchanged to DDM (N-dodecyl-β-D-maltoside) (0.05%) or Fos-12 
(0.05%), respectively. Fos-12 in the proteomicelles of P-CF expressed mAQP4 M23 was 
furthermore exchanged to DDM (0.05%). The detergent exchange from Brij-35 to Fos-12 resulted 
in apparent aggregation and precipitation of mAQP4 M23, while the protein remained soluble after 
the substitution with DDM from either Brij-35 or Fos-12. After elution of the resulting 
proteomicelles from the IMAC column, the concentrations of mAQP4 M23 in the peak fractions 
were determined in the range of 0.7 - 1 mg/ml.   
 
Reconstitution of mAQP4 M23 into lipid bilayers is a prerequisite for the functional 
characterization of its water channel activity. The purified mAQP4 M23 was reconstituted into 
liposomes by following a previously published protocol [129]. The final concentration of mAQP4 
M23 in reconstitution mixtures was approx. 100 µg/ml. Initial attempts to destabilize preformed 
liposomes (4 mg/ml) with DDM (0.04%) were not successful, which led to very low reconstitution 
rates or in even empty liposomes. When lipid concentration was increased to 6 mg/ml and DDM 
was replaced by Triton X-100 (0.36%), the mAQP4 M23 reconstitution rate was significantly 
Figure 40. Purification of 
D-CF produced mAQP4 
M23 in 0.2% Brij-35 by 
Co2+-NTA 
chromatography. Samples 
were separated by 12 % 
(lanes 1-2) or 16 % (lanes 3-
7) SDS-PAGE and analyzed 
by Coomassie staining. 
Lanes 1 and 3, protein 
marker; Lane 2, precipitate 
after P-CF expression; Lane 
4, flow through; Lane 5, 
washing fraction; Lane 6, 
elution fraction; Lane 7, 
immunoblot of lane 6 using 
anti-His antibodies. Samples 
of 2 µl were applied to each 
lane. 
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increased. The prepared proteoliposomes could be stored at 4
o
C for up to one week. Extended 
storage as well as freezing in liquid nitrogen resulted in completely inactive proteoliposomes.  
 
Figure 41. Ultracentrifugation of reconstituted AQP4 M23 liposomes in a sucrose gradient buffer. Sucrose gradient 
was made by pooling 40%, 30%, 20% and 10% from bottom to top. The preteoliposome was loaded on to the top of the 
sucrose buffer. Centrifuge at 101,000×g at 4oC overnight. 
 
4.4.2.4 Water channel activity of cell-free expressed mAQP4 M23 
Water channel activity of reconstituted mAQP4 M23 samples obtained from either P-CF or 
D-CF expression mode was analyzed in a 100 µl reaction mixture, which was composed of 50 µl 
proteoliposomes and 50 µl reconstitution buffers with a final sucrose concentration of 200 mM. 
Reconstituted mAQP4 M23 proteoliposome and control empty liposomes were quickly mixed with 
the high osmotic reconstitution buffer by stopped-flow equipment at 10
o
C. The change of liposome 
volume as the result of water channel activity of inserted mAQP4 M23 was measured by light 
scattering at λ=436 nm (Fig. 42). All mAQP4 M23 samples obtained from two different expression 
modes and primarily solubilized in four different detergents were analyzed at 10
o
C. In all cases, the 
proteoliposomes had presented a higher water channel activity comparing with the control 
liposomes, which clearly suggested the functional reconstitution of mAQP4 M23 (Fig. 42). The Pf 
values of P-CF produced mAQP4 M23 samples resolubilized in Fos-12, Fos-16 and LPPG were 
determined as 54.4 ± 2.5 µm/s, 49.4 ± 2.0 µm/s and 50.7 ± 2.7 µm/s, respectively. The Pf value 
obtained from D-CF produced mAQP4 M23 in Brij-35 was 133.1 ± 5.6 µm/s. All control liposomes 
had an average Pf value of 25.5 ± 1.6 µm/s.  
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Figure 42. Water transport activity of P-CF and D-CF mode produced mAQP4 M23.  
Precipitates of P-CF produced mAQP4 M23 were resolubilized in the indicated detergents. The solubilized proteins were 
purified by Co2+-NTA chromatography, the initial detergent exchanged to 0.05 % DDM and the samples were 
reconstituted into E. coli polar lipids. Water transport activity was determined by stopped-flow light scattering 
measurements of mAQP4 M23 proteoliposomes at 10oC. A 200 mM osmotic gradient was established by rapidly mixing 
vesicles suspended in reconstitution buffer with an equal volume of reconstitution buffer + 400 mM sucrose. Data 
represent the average of three independent measurements. Fitted curves of mAQP4 M23 proteoliposome light scattering 
are shown. Solid line, mAQP4 M23 proteoliposomes; Dashed line, E. coli polar lipid empty liposomes. 
The water channel activity of aquaporins can be inhibited by the binding of HgCl2 to 
essential cysteine residues in the protein [169]. Pre-incubation of proteoliposomes containing D-CF 
produced mAQP4 M23 with 300 µM HgCl2 at 25
o
C for 5 min resulted in a clear reduction of the 
water channel activity from 158.3 ± 3.0 µm/s to 103.8 ± 2.7 µm/s (Fig. 43). The inhibition was 
partially reversible by treatment with ß-mercaptoethanol, which was presumably due to the 
regeneration of the essential thiol-residues, and the related Pf value was recovered to 126.0 ± 2.8 
µm/s. The Pf value of empty liposomes was 55.9 ± 3.7 µm/s, with or without the treatment of HgCl2. 
The established complete process for the preparative scale CF production of mAQP4 M23 from 
expression to functionally active protein therefore takes no more than 2 days (Fig. 44).  
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Figure 44. Flow-chart of mAQP4 M23 production by CF expression.  
The complete process from expression to functional analysis is finished within 2 days. 
 
 
 
 
 
 
 
 
Figure 43. Specific inhibition of 
mAQP4 M23 water transport.  
Proteoliposomes containing D-CF 
produced mAQP4 M23 were treated 
with 300 µM HgCl2 for 5 min. at 
23oC. For the recovery of the 
function of mAQP4 M23 function, 2 
mM β-mercaptoethanol (β-ME) was 
added and incubated 10 min. at 23oC 
after incubation with HgCl2. Empty 
liposomes with and without 
treatment by HgCl2 were used as 
control and showed identical curves 
(dashed line). 
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5. Discussion 
5.1 Establishing high-throughput cell-free expression platform 
5.1.1 Setting up an automated cell-free expression platform for screening parameters 
In the traditional throughput protein expression approaches, very limited expression 
parameters can be screened mainly focused on changing the vector or host environments. The 
sensitive physiology of living cells and membrane barriers do not allow extensive variations of the 
expression protocols. Therefore, expression conditions of quite a large number of target proteins are 
quite identical. The low successful rate does not improved further even with the normal 
optimization of expression conditions. However, those targets, which seemed hard to express with 
traditional approach are quite often the targets with great interest, i.e., toxins, MPs, aggregation-
prone proteins, and unstable sensitive proteins like enzymes. 
With the development of CF expression technique, the strategy and expression parameters 
can be completely different from traditional in vivo approach and more versatile. Without the 
membrane barrier and other metabolic process of living cells, CF expression system provided 
efficient machinery for protein expression. In addition, the open nature of CF expression system 
allowed a large number of different expression parameters to be introduced in the system directly to 
address specific expression problems. For instance, the hydrophobic characterization of MPs always 
made them difficult to be expressed and analyzed. In addition, some MPs directly lead to the death 
of the host cells when overexpressed. In contrast, the CF expression system can introduce large 
number of natural or artificial compounds to the system directly to address the expression and 
folding problem for those difficult targets. For instance, introducing detergents and lipids will MPs 
soluble and functional folded when expressed (see the part 1.3.2.4). 
With the increase of expression parameters that can be optimized and screened, a more 
efficient and fast expression CF platform is therefore required. This platform should not only able to 
provide a platform for large number of targets expression screening, but more importantly provide 
the platform for individual expression protocol development. Therefore, a more complicated 
compounds concentrations screening is desired. Since a larger number of screening experiments are 
required for this screening purpose, a robotic device which can provide a precise pipetting work is 
therefore necessary. In addition, the selection of suitable CF expression protocols is also critical for 
establishing such an automatic throughput system.  
Quite a lot of CF expression protocols are published and modified for various application, 
among them the batch CF expression system with the easy setting up in one compartment and 
around 1 mg protein per 1 ml reaction volume [78, 133] is the most suitable CF system for 
throughput platform. Besides the easy set ups of the batch system, the possibility to minimize the 
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reaction volume is also a beneficial parameter for successful throughput application, considering the 
cost of screening. Low volume like a few microliters can be directly transferred to micro-plate 
where the reaction can be hold and incubated for protein expression.  
With the combination of batch CF expression system and the robotic pipetting system 
TECAN Freedom EVO 200/8, a prototype of the throughput CF expression system with the purpose 
of condition screening for specific target can be successfully set up. In order to perform fast and 
precise pipetting, liquid handling arms with 8 channels was introduced, which can precisely 
pipetting the volume between 300 nl to 750 µl at once. Besides, in order to handle different liquid, 
three different liquid classes are therefore defined. As indicated in 4.1.2, a custom designed software 
E.Y.E.S program which can create worklists for the robot operation system Germini to carry out 
was introduced. With this software, the design of the screening experiment is quite straightforward. 
The whole screening experiment then can be carried out in the following steps: creating a common 
master mix and aliquot in to each well; pipetting all the screening compounds and additives; 
supplement with H2O; adding start reagent to start the expression; incubating and quantification.  
Based on the “Cytomim” system, which was established for soluble protein expression and 
reported to have a relative high yield, we systematically screening the optima concentrations for 
most of the important compounds like those energy precursors, NTP mix, and T7 polymerase. After 
optimization, a stable soluble expression yield of sGFP around 500 µg was obtained with the 
minimum reaction volume of 25 µl in a V-shaped 96-well plate. 
5.1.2 Developing individual expression protocols 
There are several different CF expression protocols available. They can be classified with 
the different source of extract: like the E. coli [170, 171], wheat germ [172], yeast [45], insect cell 
[43, 173],  and rabbit reticulocyte [174]. Even with the most well developed E. coli systems, they 
differed in energy source and other precursors like NTPs. The concentration of each compound 
needed to be optimized. Although recommended concentrations are given in those protocols, in 
practice, those concentrations are highly depend on individual setting ups. That is why in the stage 
of CF expression protocol development for specific target required rescreening several basic 
compounds. Small changes in the concentration of specific compounds are often not avoidable, 
therefore this always cause the decrease of the efficiency of the whole system. As indicated in 
Fig.14, the difference of optima Mg
2+
 concentration is around 4 mM, which can lead to more than 
20% decrease in the expression yield if use the optimum Mg
2+
 concentration from another.  
Therefore it is recommended to re-optimize several key compounds like Mg
2+
, T7 polymerase, S30 
extract and so on to obtain the basic expression protocol.  
A systematic screening of several basic compounds was shown in Fig. 11. Different 
compounds had different effluence on the expression yield. Compounds like S30 extract and Mg
2+
 
showed quite sharp curve with fixed optima concentration. While NH4
+
 showed less influence on 
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the expression with quite wide range of tolerance. DTT act as a reducing reagent showed a 
compatible concentration around 2 mM. Further increase will cause the decrease in the expression 
yield.  Linear screening of the compounds concentration would give the information on the 
independent effect of the compounds on the efficiency of CF expression system. However, the 
influence of the interaction between different compounds on the efficiency was not analyzed and 
most likely ignored. 
DNA template played a crucial role in the CF expression. Different studies were done in 
order to improve the design of the template. For instance, with different N-terminal sequence, the 
stability of the transcribed mRNA [175] can be improved therefore a stable high concentration of 
mRNA can be achieved. High level of mRNA will greatly improve the expression yield. In the 
procedure of over production of recombinant protein, the translation initiation [176] play a crucial 
role. With the tag variation strategy, which adding a short non-functional tag sequence on the 5’ 
coding region of the protein, we successfully optimized the expression of large eukaryotic MPs to a 
high expression level (above 1 mg per 1 ml reaction mixture) [177].  
In this study, we screened the template concentration in our batch system to find the 
optimum. As shown in Fig. 12, the expression yield reached a plateau with the template 
concentration around 2-4 ng/µl. Linear template was very convenient for perform different target 
screening and especially for throughput applications, an overlap PCR strategy was developed to 
create suitable linear template for CF expression [70]. In order to check the efficiency of the linear 
template, the comparison experiment with the traditional plasmid template was performed. As 
shown in Fig.13 with equal weight of linear template and plasmid template, the expression yields 
were the same. However, with equal molar concentration ratio the expression yield was only 30% 
compared to plasmid template. This decrease was probably due to the instability of the linear 
template. 
5.2 Introducing chemical stabilizers into the cell-free expression system 
5.2.1 Evaluation of chemical stabilizers in cell-free system via sGFP 
The development of CF technology allowed high-throughput application in proteomics. 
Especially, for large number of targets or mutations, protein samples can be obtained with hours. 
However, to process large number of reactions was still quite challenging and time-consuming if 
handled manually. Several previous study already showed the possibility to automate the pipetting 
process of CF reactions [103, 131]. We introduced the Tecan Evo 200
®
 robotic pipetting system, 
together with custom designed software E.Y.E.S, to perform the pipetting of CF reactions. With this 
platform, large number of CF free reactions can be performed with a short time periods. In addition, 
with the usage of throughput monitor methods like fluorescent measurement, the evaluation of the 
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screening also can be performed in the throughput form. With this a throughput strategy can be 
achieved for both large proteomic studies.    
Quite a lot of researches were done for the throughput application of CF system. However, 
most of them were based on improving the successful expression of targets [103] or specific 
application of one type of proteins [102, 178]. A few researches were done to combine CF system 
and specific protein functional assay to obtain a high-throughput platform, which can be used for 
protein evolution screening [179] or drug screening[180]. However, our aim was to address those 
proteins which are difficult to be expressed or to be functional expressed via the CF expression 
systems. Use the open nature of the system itself to develop a strategy to handle those difficult 
targets. It was often found that quite large number of difficulty proteins, i.e., aggregation prone, 
toxic, and MPs could not be addressed by traditional in vivo expression system and also not easily 
handled in vitro CF system. Therefore we took the advantage of CF system as an open system and 
amendable for throughput automation to develop an application of systematic screening of chemical 
compounds co-translational, which in previous reports beneficial for protein production, stability 
and folding.  
 
Taking the advantage of fast evaluation of fluorescence, sGFP was taken as the monitor of 
the CF expression system. Molecular crowding reagents (PEG, Ficoll) were used to mimic the 
environment inside the cells and the effects on CF expression system were studied recently. Results 
showed that these macromolecular crowding reagents showed a beneficial effect on the transcription 
level, while an inhibitory effect on the translation level. In this study, an increase of 2.2 fold 
proteins yield can be achieved with applying macromolecular reagent in the transcription process 
rather not in the translation process [181]. Considering the overall effect of transcription and 
translation, we observed an overall beneficial effect of PEG on the expression of sGFP, up to 20% 
increase. In addition, via correlated screening of PEG and Mg
2+
, we observed an interaction of these 
two compounds. As a result, the effect of Mg
2+
 can be supplemented by certain amount of PEG, 
without losing the final protein yield.  
Furthermore, chemical compounds which acted like protein stabilizer were also evaluated. 
From the evaluation we found most of the tested protein stabilizer had no or less inhibitory effect on 
the CF system itself. In order to give a general guide for choosing proper stabilizers, we classified 
all the compounds into three levels. For those compounds like ethanol, choline and the amino acids 
gave an increase in the protein yield can behave like expression enhancer and as well as protein 
stabilizer. While for the tolerant compounds like methanol, isopropanol, betaine, ectoine, sugars, 
and polyols which did not result in the increase of the protein yield, still could be used within 
certain concentration (indicated in Tab. 7) to stabilize specific targets during expression to obtain 
more functional form of proteins. Compounds like butanol, petanol, haxanol, PEI should be avoided 
because they almost completely killed the system with very low concentration. Important 
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information for this kind of screening was that all these compounds were available to protein 
immediately when they were produced. They act as co-translational, not post-translational partners. 
With this one can expected better protection and more functional protein recovery rate.  
As shown in the screening of basic compounds, there might be an interaction between two 
compounds which influenced the final expression of the CF system. In the screening of PEGs and 
alcohols, different Mg
2+
 concentrations were used as shown in Fig. 20 and Fig. 24. For the screening 
of alcohols, the effect was basically the same with different Mg
2+
. Ethanol was the only alcohol, 
showing an increasing effect on the expression of sGFP. The increase of yield reached nearly 3 fold, 
compared to the control, with low Mg
2+
 concentration. While, with high Mg
2+
 concentration, the 
expression yield increased 60%. The same situation was found in the case of PEG. With low Mg
2+
 
concentration, the PEG6000 will really increase dramatically the expression yields, up to 4000%. 
With high Mg
2+
, most of the PEG had a 20% increase. In the case of PEG, we assume that the effect 
of reducing Mg
2+
 on the expression yield can be implemented by adding certain amount of PEG. 
5.2.2 Evaluation of chemical stabilizers on improving soluble expression of proteins in 
cell-free system 
We select two targets: Halogenase [182] and GNA1, which tend to form insoluble form 
during expression in vivo or in vitro. Halogenase, when expressed in vivo required low temperature 
conditions [183], and still formed quite a lot of precipitated form (data not shown). GNA1 also tent 
to form precipitate when expressed in CF system. For further proof of the principle to using these 
stabilizers to generate a beneficial effect on the protein stability and folding, we pick up several 
stabilizers to test their effect on the solubility and function of the two targets. Among the selected 
stabilizers, L-arginine and choline showed beneficial effect on the soluble expression of Halogenase. 
The soluble expression improved up to 8% or 25%, when using 10 mM L-arginine or 10 mM 
choline as additives. 
Results of GNA1 also showed that with both choline and L-arginine, the soluble expression 
was improved. However, the fluorescence of fusion protein might be influenced by sGFP itself. 
Comparison of sGFP indicated that both two compounds had beneficial effect on sGFP folding, 
since the ratio of supernatant and pellet of sGFP increased. Result of enzymatic assay in presence of 
choline was consistent with the fluorescence data. But, for L-arginine the enzymatic activity was 
slightly reduced while the fluorescence was improved with addition of 10 mM L-arginine. This 
effect probably due to the folding of GFP was improved by Arginine [184], but not the GNA1. In 
this case, the fluorescence did not correlate with the function of the target protein. However, we 
select two compounds, PEG8000 and choline, to present an example of correlated screening of two 
compounds which act either as expression enhancer or protein stabilizer. As indicated in Fig. 29, 
when combine the two compounds, more soluble expression was observed than the sum up of using 
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each single compound. When using PEG8000 alone, an increase of soluble expression was observed 
around 17% was observed. While with choline alone around 23% more soluble expression was 
achieved. While when using both PEG8000 and choline at the optima concentrations, an increase of 
around 60% was obtained. This 60 % increase was much more than simply sum up of the 17% and 
23%. Which might indicate an additional beneficial effect came from the interaction of the two 
compounds. 
5.3 Application of throughput cell-free expression system on membrane 
proteins 
5.3.1 Fast evaluation of membrane protein expression 
The usage of green fluorescence protein (GFP) as a folding indicator in vivo provided an 
efficient tool for MPs expression. The folding of GFP was used as a monitor if the overexpressed 
MPs fusion partner was end up with inclusion bodies or inserted to membranes.  Successful method 
was developed with both prokaryotic E. coli expression system [144] and eukaryotic yeast system 
[185]. Taken the same idea for the CF expression system, we introduced the construct of MPs fused 
with GFP at the C-terminal. However, the successful usage of the GFP as a monitor in the CF 
expression system was largely depended on the folding of GFP in presence of detergent, since the 
hydrophobicity of MPs. However, with previous results, the fluorescence was dramatically decrease 
in most of the detergents, like TritonX-100, maltoside, glucoside, Digitonin and so on [102]. Finally, 
the best folding of GFP was observed in polyoxyethylenes or phosphocholines derivatives, which 
still retained around 30-55% of the fluorescence (shown in Fig. 30 and [102]). With this reduced 
signal it might be sufficient for the first analysis of soluble MPs expression in D-CF mode. However, 
detergent screening of MPs fused with GFP only showed high fluorescence in Brij-78 and Brij-58. 
Therefore, most of the D-CF mode expression of MPs fused with GFP was performed with the Brij-
78 and Brij-58 [102].  
However, with more target tested, the effect of C-terminal GFP folding really limit the 
application of this method, due to the fact that there were many MPs which cannot be expressed 
soluble in Brij-78. In addition, there was still quite some part of the soluble expressed MPs which 
did not give the fluorescence signals. In order to address this problem for the application of high 
throughput CF platform in MPs, we select a new mutant of GFP which should an improved stability 
and faster folding compared to the normal GFP [147]. Due to the fast folding property of the 
superfolder GFP, the tolerance to different detergents might be much better. Experiment which 
compared the folding of normal shifted GFP (sGFP) and superfolder GFP was performed. As 
indicated in Fig. 30, the sGFP did not show fluorescence in quite some detergent, like DDM, 
TritoX100, Digitonin, fluorinated surfactance and Nvoy. However, the superfolder GFP exhibit a 
broader detergent resistance, in Brij-78 the superfolder GFP fold up to around 100%. With detergent 
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like TritonX-100 and Brij-35, Digitonin, DDM the folding of the superfolder GFP were still above 
70%. For the case of CHAPS both sGFP and superfolder GFP did not give high fluorescence signals, 
this might due to the inhibitory effect of the detergent on the CF expression system itself. 
With the promising results from the detergent tolerance experiment of this superfolder GFP 
(Fig. 30), further analysis of MP expression using the superfolderGFP was performed. This example 
was given for the detergent screening of soluble expression for SugE (a small multidrug transporter) 
with two different GFP fusions. As shown in Fig. 31, compared to the most well folded Brij-78 for 
sGFP fusion construct, the superfolder GFP fusion construct also showed good fluorescence (above 
80% compared to the control in Brij-78) in detergents like Digitonin and Lauryl-MNG. Overall, 
with all the detergents selected, the superfolder GFP fusion construct showed much higher 
fluorescence than the normal sGFP, especially with Brij-58 showed higher fluorescence than the 
positive control with Brij-78. 
5.3.2 Improving the membrane proteins translocation with lipids/detergent mixtures 
Since MPs are targeting at the bio-membrane, therefore in several cases, lipids are required 
for the functionally or folding of certain MPs. Although detergent micelles can also provide 
hydrophobic environment, lipids sometime are necessary. Taking this effect into consideration, 
experiment which try to introduce additional lipids together with the detergent into the CF 
expression system. As summarized in Tab. 8, different MPs including large target like 
bacteriorhodopsin and ATP synthase were functional produced in lipid/detergent environment, with 
increased functionality than using detergent alone (see 4.3.3). 
5.4 Characterization of cell-free produced membrane proteins 
5.4.1 Strategy for preparing homogeneous membrane protein sample 
One important parameter for sample quality is its homogeneity. Different methods like SEC, 
EM and other spectroscopy methods to characterize the sample status. The select SugE (small 
multidrug transporter) protein was chosen for further sample quality optimization. The SugE protein 
was highly expressed in P-CF mode as precipitates and later on resolubized in detergents to form 
soluble sample. P-CF produce SugE with its native N-terminal and C-terminal amino acids sequence 
was evaluated via SEC. As shown in Fig. 33, re-solubilized sample showed different elution profile 
on the SEC column. For example, the β-OG resolubilized SugE showed a very broad peak over the 
whole elution time, indicating a multimeric oligomer status or even aggregations. While the DDM 
sample showed a single sharp peak, which indicated a more homogeneous sample than in TritonX-
100 and β-OG. 
Since the construct was without any affinity tags for purification, special strategy was 
developed for a purification purpose. With a mild detergent like NDSB256 was first used for the 
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resolubilization. However, NDSB256 only solubilize the impurities and very few of the SugE target. 
A second step of resolubilization with other detergent like DDM was used to mainly solubilize the 
SugE protein. With this two-step resolubilization, a relative pure solubilized protein can be obtained 
(shown in Fig.34). However, after the resolubilization, the sample was still now pure and quite some 
other impurities remaining. SEC was then used to further purifying the protein sample. The peak 
fractions that were collected and pooled showed a relative pure band on a SDS-PAGE (see Fig. 35). 
With this particular purification protocol, this MP SugE was purified to homogeneous and further 
structural studies can then be performed with this sample. 
The hydrophobic environment for MPs structure characterization is crucial. The interactions 
of MPs and the hydrophobic environment are always needed to be considered when trying to 
determine the structure of a MP. Especially, for MPs crystallization, the role of detergent for getting 
well diffracted MP crystals is important. Therefore, a lot of studies have been done to characterize 
the effect of different detergent on the crystallization process [186]. Several detergents have been 
used frequently for MPs crystallization like DDM, β-OG, LDAO, and so on[186]. Some derivatives 
of these detergents with modification of the alkyl chain were created in order to provide different 
sized micelles. The experiment of detergent exchange on a SEC column provided more information 
for potential detergents that can be used for crystallization conditions screening (Fig. 36). We 
observed in this experiment, with small micelle, the peak shape of the SugE on the SEC was less 
homogeneous. This can be explained by that small micelles had problem to hold the protein stable. 
However, small micelles can provide a better protein-protein contact which might facilitate the 
crystallization. Therefore, exploring more detergents which can keep the MPs stable with small 
micelle was necessary to improve the success rate of crystallization. As shown in Fig. 36, the SugE 
sample behaved the best in DDM. However, the NM and DM sample showed a very close double 
peak, this might due to the change of detergent micelle from DDM to NM or DM. For the sample in 
FG, NG and OG, the peak looked broad with a small shoulder, which might indicate inhomogeneity. 
Finally, the C8E5 and C10E5 also showed relative good peaks. With this experiment, more 
detergents which showed comparable protein quality can be used for the further crystallization. In 
the early elution volume, there is a huge peak appeared in nearly all the elution profile. By checking 
the absorbance of 260 nm, we find this peak might be some nuclear acids. And after peak collection 
of the protein sample, this peak was disappeared. 
Although the first crystallization screening only showed small crystals of detergent, the 
results of detergents screening and purification procedure provide an example of quality 
optimization of CF produced MPs. 
5.4.2 Functional characterization of cell-free produced mAPQ4 M23 
Aquaporins are a ubiquitous class of MPs present in prokaryotes and eukaryotes that 
provide the cellular gatekeepers for water as well as for other small molecules such as glycerol. In 
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human, 13 different and tissue specific AQPs are responsible for transport mechanisms and showed 
considerable clinical relevance [4]. AQP4 is expressed in the brain and thought to be primarily 
responsible for cerebral water homeostasis [187]. This protein is an important central regulator of 
cerebrospinal fluid which has to be very tightly controlled in order to prevent intracranial pressure 
resulting in compression of brain tissue, neurological disorders and even cell death. The two 
isoforms of AQP4 resulting from two optional translation initiation sites at methionine M1 or M23 
are very unique. The shorter M23 isoform favors larger array formation in distinct tissues based on 
improved intermolecular contacts [188, 189]. Several structural information of AQPs has already 
been obtained by X-ray crystallization. The abundant AQP0 and AQP1 could be isolated in 
sufficient amounts from natural tissues whereas AQP4 and AQP5 were heterologously expressed in 
yeast cells [190-193]. However, obtaining sufficient amounts of functional AQP samples still 
remains challenging and hampers their detailed molecular study. In addition, developing and 
screening for therapeutic drugs targeting on AQP4 would be valuable in addressing damages caused 
by stroke, edema, epilepsy and other CNS disorders.  
 This report demonstrated the first example for the preparative scale CF production of a 
functional eukaryotic AQP. Expression of rAQP4 that is approx. 92% identical to the mouse AQP4 
has been approached in conventional in vivo systems before. But the expression in E. coli was not 
successful, and only a few µg of rAQP4 per liter of culture could be obtained from Pichia pastoris 
[194]. Best expression rates of up to 3 mg/l were obtained in Sf9 cell cultures after 72 hours 
infection [11, 194]. Summarizing from recent reports associated with AQP production, up to 15 
mg/l hAQP4 could be produced in P. pastoris [193]; 3–5 mg/l of Methanothermobacter 
marburgensis AQPM was produced in E. coli [195]; 0.5 mg/l of human AQP2 was expressed in 
insect cells [196]; 9–13 mg/l of E. coli AQPZ was produced in E. coli [197] and 25 mg/L of spinach 
AQP-PM28A was produced in P. pastoris [198]. It was further suggested that construction of large 
fusion proteins may further improve the expression of AQPs [199]. However, most of AQPs are still 
difficult to produce, and solublization of overproduced AQPs from cellular membrane remains a 
challenging task. With the established CF expression protocol in this report, we were able to 
generate soluble and functional mAQP4 M23 within 24 hours. In addition to the considerably 
shortened expression time, the downstream purification process is significantly faster with the 
application of affinity purification column. The handling volumes by using CF expression 
technology are much smaller and expression rates of mg per ml can be achieved if compared with 
mg per litres with in vivo expression systems. This strategy will therefore dramatically accelerate 
the preparation of bioactive AQPs for both functional and structural assays.  
 The E. coli AQPZ was previously synthesized in a similar CF system using the batch 
configuration [200]. The protein was directly synthesized into preformed artificial liposomes that 
have been added into the reaction, resulting into proteoliposomes. In this study, we have used two 
different CF expression modes that both provided solubilized mAQP4 M23 samples, representing 
Discussion 
 
-95- 
 
the preferred samples for structural analysis. In the P-CF mode, the protein was first precipitated 
and then post-translationally solubilized by detergents. In the D-CF mode, the mAQP4 M23 was co-
translationally solubilized by detergents supplemented into the CF reaction. The results of water 
channel activity assays have indicated that both CF expression modes could produce functionally 
folded mAQP4 M23, while higher Pf values were obtained from D-CF samples. Osmotic water 
permeability values (Pf) in reconstituted mAQP4 M23 proteoliposomes were calculated according 
to the results derived from light scattering assays and can be compared with corresponding values in 
the literature. The measured Pf values of ~133 µm/s for mAQP4 M23 produced by D-CF at 10
o
C 
are comparable with reported Pf values of 28 µm/s for AQPZ at 6.5
o
C [130], Pf values of 57µm/s 
for AQPM at 4
o
C [195], and Pf values of 112 µm/s for rAQP4 expressed in yeast at 10
o
C [169]. 
Considering high variations in reconstitution rates and the assay temperature bias, our data obtained 
from the CF expressed mAQP4 M23 are in good agreement with the above mentioned Pf values. 
The lower Pf values of the P-CF produced samples at approx. 50 µm/s might also be a result of 
different reconstitution rates as different detergents were used for mAQP4 M23 solubilization.  
 Several higher Pf values of approx 200 µm/s of mAQP4 M23 are reported in the literature 
[201]. However, one should notice that most high Pf values were obtained by in vivo functional 
assays [201]. Pf values calculated by in vitro assays after reconstitution into artificial liposomes 
were usually below or around 100 µm/s, e.g. 89 µm/s [202] or 117 µm/s [169]. In addition, lower Pf 
values (around 75 µm/s) were further observed in other in vivo measurements [203]. While there 
still potential exists for quality optimization of CF produced AQP in future, the functional parameter 
Pf clearly appears to be influenced by a number of factors which have to be considered if different 
samples were compared.  
 In the present work, two different CF expression approaches were developed that obtained 
sufficient amounts of functional eukaryotic AQPs within a short time. The presented protocols could 
be useful for structural characterization as well as for industrial applications of water filtration such 
as proposed by Swartz 2006 [12]. Lipid bilayers with functional AQP could be immobilized on top 
of porous supports e.g. regenerated cellulose. With the specificity and high permeability of the 
selected AQP, only water can pass through the membrane while contaminants like ions and other 
molecules were not transported. This prototype could therefore provide an alternative way for water 
filtration. However, the requirement of large amounts of functional AQPs is the key bottleneck of 
this application. 
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6. Perspectives 
 
With the established high-throughput CF platform, more applications in addressing 
challenge targets are possible and more efficient, especially MPs. Preliminary work of using a 
superfolderGFP as monitor for MPs expression and even folding enable both large number of MPs 
target expression screening and target specific condition screening. More researches needs to be 
done in the future to further improve this platform and set up a general standard optimization 
strategy for MPs expression, purification suitable for functional and structural characterization. 
New nanoparticle technology with different set ups like lipid/detergent mix (bicelles or 
detergent solubilized liposomes) and nanodiscs (lipid/protein) are merging to optimize the 
hydrophobic environment. However, still quite lot of research need to be done to proof the 
advantage of these new approaches. In combination with the throughput CF platform, it will be 
more efficient for applying these new nanoparticles to selected MPs. 
Successful examples of functional produce AQP4 M23 in different CF expression mode, 
both P-CF and D-CF, proved that eukaryotic MPs can be successfully produced with the E. coli 
based CF expression system with very high yield. It is always a good choice to select the most 
simple and efficient system to start with. However, in the future, a combination of prokaryotic and 
eukaryotic CF system would be more attracting, which retain the high efficiency of protein 
production and the post-translational modification for the functional folding.  
The advantage of CF expression system for providing protein sample for structural study 
was already recognized. Especially for NMR study, selective labeling and very less scrambling with 
different amino acids compared to traditional in vivo expression system are the biggest advantages. 
High expression yield and less time-consuming purification process is also attractive for obtain 
large amount of homogeneous sample for structural approach. 
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8. Appendix  
8.1 Standard curves 
8.1.1 Standard curve of sGFP  
 
8.1.2 Standard curve of superfolderGFP  
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8.1.3 Calibration curve of size exclusion chromatography columns 
 
Superdex 200 3.2/30 
 
Superdex 200 10/300 
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